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Abstract 
The elderly population is among the fastest growing populations in the United States. 
Finding and consuming medications safely and effectively are challenging endeavors for 
this population. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a widely consumed 
class of medications among the elderly population, with 70% of individuals consuming 
over-the-counter (OTC) NSAIDs once a week and 34% using them daily. The purpose of 
this quantitative study was to determine whether (a) patients are aware of the risks 
associated with the consumption of NSAIDs, and (b) there are differences in awareness 
based upon specific demographic characteristics and levels of patient-physician 
communication. The health belief model (HBM) was used to interpret the results. The 
HBM is a social cognition framework that takes into account different perceptions, 
namely, perceived susceptibility of acquiring a health condition, perceived severity of the 
condition and its consequences, perceived barriers to engaging in the recommended 
behavior, perceived benefits of engaging in the recommended behavior, and perceived 
costs of engaging in the recommended behavior. Multiple linear regression was used to 
analyze the data. The results, which were based upon a cross-sectional survey of 124 
participants, showed that the participants’ awareness of adverse events associated with 
NSAIDs use was not associated with sociodemographic variables, rates of consumption, 
or patient-physician communication. The findings will give the key stakeholders more 
insight into the issue of preventable adverse events that might lead to the establishment of 
more safety programs and informatics structural systems to monitor the consumption of 
OTC NSAIDs and improve lines of communication to protect the elderly population.  
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Chapter 1: Introduction 
Background of the Study 
The elderly population is continuing to grow. In 2009, 39.6 million people 
representing approximately 13% of the population in the United States, or one in every 
eight Americans, was over the age of 65 (U.S. Department of Health and Human Services 
[DHHS], 2011). The DHHS (2011) estimated that by 2030, there will be 72.1 million 
people over the age of 65 in the United States. The elderly population can find consuming 
medication safely and effectively a challenging endeavor. Elderly individuals often have 
one or more comorbidities or chronic disorders that can result in an increased 
consumption of the number of medications.  
Kaufman, Kelly, Rosenberg, Anderson, and Mitchell (2002) reported that in the 
United States, elderly individuals consume at least one over-the-counter (OTC) or 
prescribed medication each week and that approximately 25% consume five medications 
on a weekly basis. Individuals in the elderly population (i.e., age > 65 years) are at higher 
risk than younger adults of experiencing adverse events associated with medications 
because of age-related physiological changes, possible multiple chronic conditions, and 
high consumption of prescription and OTC medications (Barkin et al., 2010; Chutka, 
Takahashi, & Hoel, 2004). Adverse events resulting from taking prescription and OTC 
medications include falls, cognitive loss, dehydration, incontinence, depression, loss of 
functional ability, hospitalization, and decreased quality of life (Chutka et al., 2004). 
In developed countries, approximately two thirds of individuals ages 65 years and 
older will at some point take prescription and OTC medications (Mangoni, Jansen, & 
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Jackson, 2009). Prescribed and OTC nonsteroidal anti-inflammatory drugs (NSAIDs) are 
the mostly widely used class of medications globally (Kovac, Hourston, & Weinberger, 
2010; Lanas & Ferrandez, 2007) as well as in the United States (Abraham et al., 2005). In 
2000, the prevalence of self-medication was approximately 92%, and about 55% of OTC 
medication users consume more than one medication annually (Wertheimer & Serradell, 
2008).  
Some countries monitor the number of OTC medications purchased and 
consumed by their citizens. For example, Balbuena, Aranda, and Figueras (2009) 
reported that the consumption of OTC medications was approximately 46% of the 
population in Spain and over 60% in Cuba. Balbuena et al. also studied the incidence of 
self-medication among older urban Mexicans and found that people tended to self-
medicate if they lived alone, had low literacy levels, were poorly educated, and/or had a 
low socioeconomic status (SES). In the United States, OTC purchases are not monitored; 
therefore, identifying the characteristics of individuals who are the most likely to self-
medicate has been difficult. The Balbuena et al. study also revealed that according to a  
survey conducted in Denmark, there was a greater difference in the use of prescription 
drugs among individuals with a lower SES, but not in their consumption of OTC 
medications. Balbuena et al. also reviewed a survey of individuals in the Spanish 
population that indicated a significant association between self-medication and a higher 
level of education, gender, lower age, and smoking habit.  
There have been insufficient data in the United States regarding the relationship 
between levels of education, gender, ethnicity, marital status, living arrangements, and 
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income and OTC medication consumption, including NSAIDs, the most popular class of 
medications. However, OTC NSAIDs (e.g., acetaminophen, ibuprofen, and aspirin) are 
the most commonly consumed medications, with 17% to 23% of the population 
consuming them each week (Fendrick, Pan, & Johnson, 2008). Harris Interactive (2005) 
completed a survey in the United States of more than 2,000 adults indicating that more 
than 30% of OTC analgesics are consumed regularly because of chronic pain or arthritis.  
According to the National Consumers League (2009), in the United States, more 
than 175 million people are taking OTC medication for pain. Wilcox, Cryer, and 
Triadafilopoulos (2005) contended that 36 million Americans are taking OTC pain 
medications daily and approximately 23 million are taking NSAIDs. Whether 
medications are prescribed by physicians or purchased OTC, the use of NSAIDs in the 
United States increases with age (Conaghan, 2012). Based upon the consensus reached by 
a force that included the American College of Cardiology, the American College of 
Gastroenterology, and the American Heart Association, 70% of individuals in the elderly 
population consume NSAIDs once a week, and 34% use them daily (American College 
of Cardiology Task Force, 2008).  
Kaufman et al. (2002) estimated that 80% of adults in the United States will take 
OTC medications at some point in their lives to relieve pain. Among individuals who 
consume prescription NSAIDs, Wilcox et al. (2005) reported that almost 50% consume 
OTC NSAIDs concurrently and that 26% of OTC NSAIDs users consume more than the 
recommended dosage, as compared to 8% of prescription NSAIDs users. The 
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consumption of NSAIDs also has been found to be more frequent among female 
individuals and that it increases with age (Lanas & Ferrandez, 2007).  
In a self-medication survey on OTC medications, Neafsey and Shellman (2001) 
found that 59.3% of the participants reported consuming pain medication 1 month prior 
to the survey. In addition, 49.5% of the participants reported taking OTC NSAIDs. Of the 
participants who reported NSAIDs consumption, 46.9% reported taking NSAIDs for pain 
for 3 or more days at a time, and 36.7% reported taking NSAIDs daily for pain (Neafsey 
& Shellman, 2001).  
The high rate of consumption of NSAIDs relates to the belief that they are safe 
(Neafsey & Shellman, 2001). Individuals consume OTC medications inappropriately 
because they believe that these medications are safe. The inappropriate use of 
medications among the elderly population is particularly important to understand because 
of their increased risk of adverse events. The elderly population might consume these 
medications in doses that are higher than recommended or in combination with other 
medications that can elevate the risk of adverse events (Fendrick et al., 2008). At least 
25% of patients consuming NSAIDs experience adverse events, and many of these 
patients require medical attention or possible hospitalization (Lanas & Ferrandez, 2007).  
NSAIDs are one of the most common causes of reported serious adverse reactions 
to drugs that can involve the gastrointestinal tract, cardiovascular system, liver, and 
kidneys (Barkin et al., 2010; Pineles & Parente, 2012). The risk of adverse events 
increases not only among the elderly population but also among individuals who have 
been diagnosed with comorbid conditions. For instance, acetaminophen, a common 
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analgesic in the United States, has been reported as causing 78,414 emergency room 
visits and 26,000 hospital admissions annually (Budnitz, Lovegrove, & Crosby, 2011; 
Lee, 2007; Nourjah, Ahmad, & Karwoski, 2006). Acetaminophen overdose also has been 
linked to approximately 100 deaths annually in the United States (DHHS, 2009).  
The high prevalence of NSAIDs use among patients who are at risk of 
experiencing significant adverse drug-related events or who have chronic disease states 
that contraindicate NSAIDs consumption also is a major concern (Adams et al., 2011). 
Approximately 75% of the individuals who consume NSAIDs have one or more 
comorbidities that include cardiovascular disease, hypertension, or chronic kidney 
disease. For example, 50% of the people who consume NSAIDs have a diagnosis of 
hypertension, and an additional 33% have a diagnosis of Stage 3 or higher chronic kidney 
disease (Adams et al., 2011). In addition, 20% of individuals with cardiovascular disease 
have reported consuming NSAIDs (Adams et al., 2011). Cebollero-Santamaria et al. (as 
cited in Mangoni et al., 2009) found that bleeding from a peptic ulcer was associated with 
the use of NSAIDs in 81% of 84 patients in their study and that 95% had purchased OTC 
NSAIDs. 
In the Nurses’ Health Study 1, an 8-year follow-up study, Dedier et al. (2002) 
surveyed more than 51,000 nurses and found that the risk of developing hypertension 
increased with the frequency of NSAIDs use. Conaghan (2012) reported that NSAIDs 
consumption can be associated with an increased risk of cardiovascular events such as 
myocardial infarction, heart failure, and hypertension that is dependent upon the duration 
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of exposure. Conaghan further suggested that the consumption of NSAIDs can result in 
gastrointestinal complications in approximately 10% to 30% of patients.  
The public health research about NSAIDs consumption has focused on the rates 
of consumption among the elderly population as well as the associated risks of adverse 
events (A. Johnson, 1998; Taylor, Lemtouni, Weiss, & Pergolizzi, 2011). According to 
A. Johnson (1998), the prevalence and incidence of hypertension increase with age, a 
finding that more recent statistics have supported (Barkin et al., 2010). Thirty-three 
percent of adults in the United States have been diagnosed with hypertension, a major 
risk factor for cardiovascular disease morbidity and mortality (Neafsey, Strickler, 
Shellman, & Chartier, 2002). Overall, A. Johnson asserted that approximately 15% of 
individuals in the elderly population consume at least one NSAID and an 
antihypertensive medication, which means that in the United States, nearly 20 million 
people consume antihypertensive medications and NSAIDs concurrently.  
A large case study by Medicaid compared 9,411 patients who were taking 
antihypertensive medications to a control group of 9,629 patients who were not taking 
antihypertensive medications and found that patients who were taking NSAIDs were at 
increased risk of having to take antihypertensive medications than individuals who were 
not consuming NSAIDs (as cited in A. Johnson, 1998). In addition, the adjusted odds 
ratio (OR) for age, gender, and body mass index (BMI) further increased when 
consumption of the daily dosage also increased. For example, among patients who 
consumed high dosages of NSAIDs, the relative risk of antihypertensive medication 
initiative was 1.8 times greater than among individuals who were not taking NSAIDs, 
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and the proportion of new antihypertensive treatment attributed to the use of nonaspirin 
NSAIDs was about 10% of the cohort (as cited in A. Johnson, 1998). Patients who 
consumed NSAIDs and antihypertensive medications had a systolic blood pressure that 
was greater than 140 mm Hg, as compared to those who were consuming only 
antihypertensive medications (as cited in A. Johnson, 1998). A systolic blood pressure  
> 140 mm/Hg and/or a diastolic blood pressure > 90 mm/Hg is considered hypertension 
(Adams et al., 2011). Seven million deaths occur worldwide annually that are the result 
of a diagnosis of hypertension; in the United States, approximately 73 million people 
have been diagnosed with hypertension (Aljadhey et al., 2012). The question becomes 
one of asking how NSAIDs affects the incidence of hypertension. 
Aljadhey et al. (2012) completed a retrospective cohort study to determine the 
effect of NSAIDs on systolic blood pressure. They collected data from the electronic 
medical records of 1,340 participants in Indianapolis, Indiana. The results showed that 
NSAIDs had an impact in increasing systolic blood pressure from 2 mm/Hg to  
5 mm/Hg, depending on the NSAIDs consumed. An epidemiological study of 2,805 
people over the age of 60 years (adjusted for age, gender, BMI, coronary heart disease 
[CHD], smoking, and alcohol consumption) indicated that NSAIDs use could 
significantly predict the presence of hypertension OR = 1.4 (95% C.I., 1.1-1.7) among 
individuals in the elderly population (L. Johnson, Simons, Simons, Friedlander, & 
McCallum, 1993) because the effect is elevated within this patient population. 
Forman, Rimm, and Curhan (2007) completed a retrospective case, controlled 
study that evaluated the consumption of acetaminophen, NSAIDs, and aspirin in male 
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individuals. The results showed that the consumption of acetaminophen 4 to 5 days/week 
was associated with an increased risk of hypertension (relative risk [RR] = 1.59; 95%, CI 
1.13-2.24). If NSAIDs consumption increased to 6 or 7 days/week, there was a 
simultaneous increase in the risk of hypertension (RR = 1.38; 95%, CI 1.09-1.75). The 
use of aspirin 2 or 3 days/week also increased the risk of hypertension (RR = 1.36, 95%, 
CI, 1.14-1.61; Forman et al., 2007). The Rural Health study involved a sample of 3,117 
people over the age of 65 years (Cornoni-Huntley, Brock, & Ostfeld, 1986). The results 
of that study showed that participants who consumed NSAIDs also were taking 
antihypertensive medications and had a mean systolic blood pressure 4.9 mm/Hg higher 
than nonusers. 
Elevated blood pressure puts people at risk of adverse cardiac events. Guidelines 
from the American College of Cardiology and the American Heart Association have 
recommended not prescribing NSAIDs to patients who have had a myocardial infarction 
(as cited in Boyle, 2011). The consumption of NSAIDs (e.g., celecoxib, rofecoxib, 
diclofenac, ibuprofen, or naproxen) following a myocardial infarction has been associated 
with a 50% increased risk of death as well as an increase in combined endpoint of death 
or myocardial infarction (Boyle, 2011). As a result, there has been some evaluation of 
replacing NSAIDs treatment with alternatives such as fish oil (Maroon & Bost, 2006); 
avocados; or soybeans (Ernst, 2003). Current guidelines for NSAIDs therapy suggest that 
they should be used for the shortest time possible (Boyle, 2011). 
The consumption of NSAIDs and OTC medications is a major clinical concern. 
Because NSAIDs help to alleviate pain, the rates of consumption and misuse of NSAIDs 
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might lead to unnecessary illness and potentially adverse events. NSAIDs counteract the 
effects of commonly prescribed antihypertensive medications such as beta-blockers, 
angiotensin receptor blockers (ARB), and angiotensin-converting inhibitors by 
destabilizing blood pressure (Singh et al., 2003). The Framingham Heart Study and the 
Systolic Hypertension in the Elderly Program reported that increases in blood pressure 
correlate with an increased frequency of cardiovascular events (as cited in Singh et al., 
2003). A continued increase in blood pressure can lead to a higher risk of ischemic and 
hemorrhagic strokes, ischemic cardiac events, and congestive heart failure (White, 2009). 
The potential destabilization of blood pressure by NSAIDs can occur in less than 2 weeks 
from initiation of therapy (White, 2009). Improving health outcomes among the elderly 
population is possible when additional factors such as increasing patient knowledge and 
behavior compliance through effective patient-physician communication is considered.  
The quality of health care and the levels of communication between physicians 
and patients are related to patient outcomes (Funnell, 2011; Ratanawongsa et al., 2008; 
Verlinde, De Laender, De Maesschalck, Deveugele, & Willems, 2012). Physician 
communication should include active listening, use of open-ended questions, nonverbal 
cues, and acknowledgment of and empathy toward patients’ emotions (Funnell, 2011). 
The communication styles of physicians will correlate to patients’ medication 
consumption behaviors; levels of trust with their physicians (Funnell, 2011; Verlinde et 
al., 2012); and levels of satisfaction, compliance, and recall of medical information.  
Open and honest communication also is linked to improved outcomes related to 
emotional health, functioning symptom resolution, and blood pressure and/or blood sugar 
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control (Ratanawongsa et al., 2008). When patient-physician communication is poor, the 
risk of adverse events with patients increases. Patients and physicians need to take equal 
responsibility to improve the lines of communication to ensure that they are honest, open, 
informative, and bidirectional (Bezreh, Laws, Taubin, Rifkin, & Wilson, 2011). 
The U.S. Food and Drug Administration (FDA) changed labeling requirements 
for NSAIDs to include warnings about the consumption of this class of medications, 
namely, stomach bleeding and liver toxicity (as cited in DHHS, 2009). In the United 
Kingdom, consumption quantities of OTC analgesics have been controlled since 1998, 
but there has been a lack of control regarding who can purchase OTC analgesics in the 
United States that has put people at risk of misuse and adverse events (Pineles & Parente, 
2012). 
Statement of the Problem 
The extended life span has been the result of awareness of disease states, 
improved compliance with preventative medicine, the use of enhanced technology, and a 
concomitant expansion of an aging society (Beyth & Shorr, 2002; Lipschitz, Shmookler 
Reis, & Sullivan, 2001). People are taking more responsibility for their medical 
conditions, including self-diagnosing and self-medicating. More than 175 million adults 
in the United States consume OTC medications primarily for pain relief (National 
Consumers League, 2009). One of the most commonly consumed groups of OTC 
medications is NSAIDs. 
Individuals ages 65 years and older account for over 30% of prescription 
medication users and 50% of OTC medication users (Beyth & Shorr, 2002). The average 
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number of prescribed and OTC medications consumed by individuals in the elderly 
population in the United States is six/day; this amount increases to nine/day if the 
individuals are institutionalized (Heuberger, 2012). OTC analgesics are generally well 
tolerated and effective, but their long-term use could result in adverse effects. Seager and 
Hawkey (2001) reported that as of 2001, 16,500 people died annually and 103,000 were 
hospitalized because of NSAIDs-related complications. These statistics have remained 
constant as mortality estimates of NSAIDs-related deaths in the United States have 
continued to increase (Cryer, 2005).  
Neafsey and Shellman (2001) concluded that over 40% of people have the 
misconception that OTC drugs are weak and not harmful. In order to make effective 
decisions, individuals need to understand the risks and benefits of taking OTC NSAIDs. 
Despite the high prevalence of OTC NSAIDs use among elderly individuals, the extent to 
which these users are aware of the association between NSAIDs use and adverse 
outcomes is unknown. Although patients want to be educated about the possible side 
effects of medications (Papanikolaou & Ioannidis, 2003), physicians are reluctant to 
inform patients about the possible side effects of consuming some medications, 
particularly medications that have a low risk of adverse events. The side effects of 
NSAIDs in the United States and across the global community have become a major 
concern.  
International researchers have expressed concern about the safe and effective 
consumption of NSAIDs as well as the increased risk of adverse events among 
individuals in the elderly population because of physicians’ lack of communication with 
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patients about the safe use of NSAIDs (Motola et al., 2004). Papanikolaou and Ioannidis 
(2003) conducted a survey in Chalki, Greece, to evaluate the population’s awareness of 
side effects associated with medication consumption. The results showed that personal 
experience with adverse events was the strongest correlation of the awareness of side 
effects. If the individuals had not experienced any direct side effects from their 
medications, they had decreased levels of awareness of side effects.  
 In the United States, a gap exists in the literature in understanding the importance 
of patient-physician communication about OTC NSAIDs consumption and levels of 
awareness of adverse events. Gaining more information about the relationship between 
the demographic characteristics of individuals who are or who are not knowledgeable 
about the adverse outcomes and consumption of OTC NSAIDs, along with the level of 
patient-physician communication, might make a difference in identifying the individuals 
who might be at risk and what factors increase that risk among the elderly population. 
Most studies have focused on adverse events related to prescription medications and have 
not evaluated the ways in which sociodemographic characteristics and communication 
levels between physicians and patients impact the consumption of OTC medications, 
especially NSAIDs. 
Purpose of the Study 
The purpose of this study was to determine whether patients are aware of the risks 
associated with the consumption of OTC NSAIDs and whether differences in awareness 
are based upon specific demographic characteristics. In addition, I sought to identify the 
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extent to which patient-physician communication levels influence patients’ awareness of 
adverse events.  
Conceptual Framework 
Individuals’ attitudes and beliefs can help to explain their health behaviors 
(Boskey, 2008), which depend on the values that the individuals place on particular goals 
and the likelihood that given actions will achieve those goals (Galvin, 1992). The health 
belief model (HBM) is a social cognition framework used when studying health behavior 
(Hochbaum, 1958; Shanks, 2009; Thompson & Caltabiano, 2010). The HBM takes into 
account different perceptions, namely, perceived susceptibility of acquiring a health 
condition, perceived severity of the condition and its consequences, perceived barriers to 
engaging in the recommended behavior, perceived benefits of engaging in the 
recommended behavior, and perceived costs of engaging in the recommended behavior 
(Shanks, 2009; Thompson & Caltabiano, 2010).  
The HBM was the theoretical framework of the current study. This model focuses 
on the knowledge, attitudes, and beliefs of individuals. In other words, the basis for the 
model is to help people to access and manage their health in regard to preventing illness 
or health problems because health behavior is impacted by the beliefs or perceptions that 
a negative health condition (e.g., cardiovascular adverse event) can be avoided (Glanz, 
Lewis, & Rimer, 2002). Self-medication is an important part of patients’ medical 
behavior. It usually is the first choice for the treatment of the early symptoms of disease. 
The risk associated with using any medication inappropriately is that it can do more harm 
than good. In addition, a suggested treatment plan or intervention can be implemented 
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when an individual has a positive expectation that if the health action is followed and 
maintained, the risk of illness or disease can be avoided (Boskey, 2008).  
The HBM has been used to motivate individuals to choose positive health 
behaviors by increasing their awareness of side effects and subsequently decreasing the 
occurrence and severity of health complications (Glanz et al., 2002). The HBM was 
chosen for this study because previous use of the HBM has been found effective in 
identifying readiness to engage in a health behavior because of a perceived threat of 
disease, susceptibility of disease, potential severity, and benefits and barriers (Glanz et 
al., 2002; Hochbaum, 1958).  
I examined differences in the perceived severity of adverse events resulting from 
OTC NSAIDs use and perceived susceptibility of adverse events resulting from 
consumption. The choice to consume OTC NSAIDs might be dependent upon beliefs 
about the perceived outcomes of behavioral changes. This behavior also might be 
influenced by individuals’ attitudes toward behavioral changes and whether they 
understand the perceived severity of the adverse effects of OTC NSAIDs consumption, 
which might result in behavioral modification. Attitudes toward medications are linked 
directly to the perceived need for drug treatment. With support from the HBM, education 
and knowledge can impact individuals’ attitudes and behaviors (Isacson & Bingefors, 
2002; Wertheimer & Serradell, 2008).  
The HBM has been used to examine the influence of physician communication on 
patients’ health care regimens (Bezreh et al., 2011). Health communication might be a 
way to improve awareness, knowledge, and health behaviors. Increasing patients’ 
15 
 
awareness of the perceived susceptibility of an adverse event related to the consumption 
of OTC NSAIDs might help to reduce or prevent such adverse events. The HBM helped 
to examine possible associations between rates of use and perceptions of risk associated 
with use. A lack of communication between physicians and patients creates a gap in 
knowledge transfer and puts patients at increased risk of preventable adverse events. This 
gap in communicating medical information can result in a lack of awareness and 
understanding of the true risks associated with the inappropriate consumption of OTC 
NSAIDs. The HBM posits that perceptions of risk can impact behavior, so I sought to 
determine whether physician communication is one area where perceived risk associated 
with OTC NSAID use might be impacted.  
Research Questions 
Three research questions and hypotheses guided the study: 
1. To what extent does the awareness of the risk of adverse events associated 
with OTC NSAIDs use vary by sociodemographic characteristics among the 
elderly (SES, race/ethnicity, gender, and education)? 
H01: There is no significant difference between awareness of the risk of adverse 
events associated with OTC NSAIDs use and sociodemographic 
characteristics among the elderly population. 
Ha1: There is a significant difference between awareness of the risk of adverse 
events associated with OTC NSAIDs use and sociodemographic 
characteristics among the elderly population. 
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2. To what extent does awareness of the risk of adverse events associated with 
OTC NSAIDs consumption vary by rates of OTC NSAIDs consumption 
among the elderly population? 
H02: There is no significant difference between awareness of the risk of adverse 
events associated with OTC NSAIDs consumption among the elderly 
population. 
Ha2: There is a significant difference between awareness of the risk of adverse 
events associated with OTC NSAIDs consumption among the elderly 
population. 
3. To what extent are levels of awareness of adverse events associated with OTC 
NSAIDs consumption and levels of communication with their physicians 
among the elderly population? 
H03: There is no significant difference between awareness of adverse events 
associated with OTC NSAIDs consumption and the level of communication 
with physicians among the elderly population. 
Ha3: There is a significant difference between awareness of adverse events 
associated with OTC NSAIDs consumption and the level of communication 
with physicians among the elderly population. 
Definitions of Terms 
  Attitude: “Learned predisposition or tendency on the part of an individual to 
respond positively or negatively to some object, situation, concept or another individual” 
(Goswami & Mahanta, 2012, p. 2). 
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Health belief model (HBM): A social cognition framework that studies health 
behavior; includes elements of an individual’s perceptions or beliefs influencing whether 
or not a health action will be initiated or avoided to prevent disease or illness (Hochbaum 
1958; Shanks, 2009; Thompson & Caltabiano, 2010).  
Perceived barriers: The potentially negative obstacles that might discourage 
behavioral changes (Thompson & Caltabiano, 2010). 
Perceived benefits: The benefits of behavioral modification (Galvin, 1992; 
Thompson & Caltabiano, 2010). 
Perceived severity: The feelings associated with seriousness in terms of health 
(disability or death) and social consequences (job or family; Shanks, 2009). 
Perceived susceptibility: Is the subjective perception of the likelihood of 
experiencing health complication/s or conditions (Shanks, 2009). 
Self-care: The care taken by individuals towards their own health and well-being; 
encompasses the actions needed to lead a healthy life; meet social, emotional, and 
psychological needs; care for a long-term condition; and prevent further illness 
(Fredericks & Sidani, 2012). 
Self-efficacy: The confidence to participate in behavioral change (Noroozi, 
Jomand, & Tahmasebi, 2011).  
Assumptions of the Study 
I made two assumptions: 
1. The participants would represent the target population. 
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2. The participants would respond honestly and openly to the survey (see 
Appendix A) questions so that their responses would reflect real perceptions. 
The participants were advised that there were no right or wrong responses.  
Limitations and Delimitations of the Study 
A questionnaire facilitated collection of the data. There was a risk of recall bias in 
that the knowledge, attitudes, and behavioral patterns reported by the participants might 
have affected the precision of the data because of concerns remembering former 
behavioral actions in regard to the consumption of OTC NSAIDs. The participants also 
could have demonstrated reporting bias. In addition, the questionnaire focused on only a 
few side effects resulting from the consumption of OTC NSAIDs, so there was the 
potential for other risks that the participants might not have been aware of as well as risks 
that the questionnaire items did not mention. Another limitation was that the participants 
could have experienced asymptomatic side effects, meaning that the number of side 
effects could have been higher than they might have been willing to reveal.  
In addition, I did not include prescription NSAIDs use, which is relatively 
common in the elderly population. Furthermore, the questionnaire did not include the 
collection of information about comorbidities, including medical conditions for which 
NSAIDs use is essentially universal (e.g., rheumatoid arthritis or osteoarthritis). Other 
comorbidities that were considered were cardiovascular disease and aspirin used for 
cardiovascular disease prophylaxis and asthma, especially when discussing risk of asthma 
attack. 
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Significance of the Study 
Knowledge of the population and patterns of OTC NSAIDs consumption among 
the elderly will help to identify groups using the medications, and this knowledge can be 
used to develop educational interventions (Wilcox et al., 2005). Such knowledge will 
help to bridge the gap between physicians and policymakers, which might then lead to 
the development of intervention programs at the local, national, and international levels. 
Improved targeting specific to the extensive consumption of OTC NSAIDs by elderly 
individuals will increase the awareness among this population about the side effects of 
these medications. In addition, researchers have identified differences in self-medication 
among health care settings and countries, thus emphasizing the need for studies at the 
local level to analyze patterns of self-medication in order to identify key elements for 
future interventions to minimize this public health problem. It is important to understand 
how physicians and patients discuss the consumption of OTC NSAIDs because better 
communication between physicians and patients might help to facilitate the early 
detection of potential drug-drug interactions, identify issues in regard to the duplication 
of therapeutic medications, and develop treatment plans to improve and/or maintain 
patients’ health.  
Nature of the Study 
This quantitative, cross-sectional study used a convenience sample of participants 
ages 65 years and older recruited from activity centers and independent living facilities 
for senior citizens in a metropolitan area in the Midwestern United States. Data were 
collected using a survey of questions from two validated instruments: the OTC Pain 
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Reliever Survey (Cham, Hall, Ernst, & Weiss, 2002). and the Perceived Efficacy in 
Patient-Physician Interaction Questionnaire (Maly, Frank, Marshall, DiMatteo, & 
Reuben, 1998). Data were analyzed using SPSS. Multiple linear regression was used to 
examine the relationships between sociodemographic characteristics and awareness of 
adverse events associated with OTC NSAIDs consumption, OTC NSAIDs consumption 
and physician-patient communication, and physician-patient communication and 
awareness of elderly individuals of the risk of adverse events associated with OTC 
NSAIDs consumption.  
Summary 
 This chapter included an explanation of the concepts associated with OTC 
NSAIDs consumption, adverse events, and physician-patient communication. Chapter 2 
provides a literature review of previous research associated with NSAIDs consumption 
and helps to identify gaps in the literature that led to the formulation of the research 
questions. Chapter 3 provides a description of the methodology that includes information 
about the study design, sample, and data analysis. Chapter 4 presents the results of the 
data collection and analysis processes. Chapter 5 includes my interpretation of the results 
based upon the current literature and theoretical framework as well as recommendations 
for future research.  
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Chapter 2: Literature Review 
Literature Search Strategies 
This chapter presents a review of the literature on knowledge and awareness 
related to the consumption of OTC NSAIDs. The purpose of this study was to (a) identify 
the relationship between the consumption of OTC NSAIDs and the knowledge and 
awareness of the elderly population about adverse drug events, and (b) understand the 
impact of patient-physician communication on the consumption of OTC NSAIDs by 
elderly individuals. The chapter presents a review of the literature on self-medication 
behaviors, the consumption of OTC NSAIDs related to sociodemographic characteristics 
and lines of communication between physicians and patients, and the side effect profile 
of OTC NSAIDs.  
A review of the literature was conducted using the Sage Online Journals, Medline, 
Google Scholar, Academic Search Premier, CINAHL, ProQuest, and PubMed databases. 
Key words in the search for relevant literature included NSAIDs, over-the-counter 
medications (OTC), side effects, socioeconomic status (SES), gender, health belief model, 
self-medication, communication, and physicians/health-care professionals. The review 
comprised more than 90 articles published between 1992 and 2013 that addressed 
prescription NSAIDs and OTC NSAIDs. Several themes emerged from the literature 
review, namely, self-care and self-medication, the latter of which is becoming a larger 
public health concern because it can result in significant economic and social 
implications for the health care system in particular and society in general.  
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Self-Care 
  The purpose of self-care by individuals, families, and communities is to establish 
and maintain health, prevent disease and illness, and control current medical conditions 
(Baig, Muzaffar, Afaq, Bilal, & Iqbal, 2012; World Health Organization [WHO], 1998; 
You, Wong, Chan, Wong, & Yeoh, 201l). Taking responsibility for personal well-being 
can involve changes in behaviors related to hygiene, nutrition, and lifestyle while also 
taking into account environmental factors, SES factors, sociodemographic factors, and 
self-medication factors (Baig et al., 2012; WHO, 1998). Self-care is the engagement in 
activities that are learned and are meant to promote healthy functioning that is the result 
of beliefs; health status; and sociodemographic characteristics (e.g., age, gender, culture, 
education, and marital status) and traits (Fredericks & Sidani, 2012). Individuals learn 
self-care behaviors within a sociocultural context, meaning that these behaviors are 
influenced by values and goals and are executed based upon ability. The components of 
ability include not only knowing what is available but also understanding the 
effectiveness and desirability of actions, judging the options available in the course of 
self-care behavior; and having the necessary resources (i.e., physical, psychological, 
emotional, and material) available to make behavioral changes (Peters & Templin, 2010). 
One example of self-care is self-medication, particularly the use of OTC medications. 
Self-Medication 
According to the WHO (1998), self-medication is the selection and use of 
medicine to treat self-recognized illnesses or symptoms. Afolabi (2012) estimated that 
approximately 50% to 75% of health care expenses are associated with self-medication. 
23 
 
Self-medication represents an area of health care in which patients assume more 
responsibility by using pharmaceutical products that are available to them without 
prescriptions from physicians (Hughes, McElnay, & Fleming, 2001). However, self-
medication is not without risks, despite the advantages associated with patient 
empowerment (Hughes et al., 2001). People might choose to self-medicate to treat 
current medical illnesses whose treatment regimens might include prescription 
medications as well as OTC medications, both of which are safe and effective when used 
as directed (WHO, 1998). However, people who choose to self-medicate must be sure 
that the medications are appropriate for their chronic or recurrent conditions and have 
proven records of safety, quality, and efficacy (WHO, 1998). These products should 
include information describing how to take or use the medications, possible side effects 
or interactions, how the effects of the medicine should be monitored, precautions and 
warnings, duration of use, and when to seek advice from physicians (WHO, 1998). 
When individuals choose to self-medicate, they take medication without 
consulting their physicians and might not even be willing to seek correct information 
about the appropriate doses or duration of the medication (Baig et al., 2012). When 
individuals choose to self-medicate, they are engaging in help-seeking behavior 
(Klemenc-Ketis & Kersnik, 2011). In order to self-medicate appropriately, people must 
identify their symptoms accurately; create therapeutic objectives; choose the correct 
medications, which includes dosage and timing; and take into account their past medical 
histories, drug contraindications, and possible side effects (Auta, Omale, Folorunsho, 
David, & Banwat, 2012). Other factors that can influence self-medication practices 
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include gender, income, self-care orientation, and medication knowledge (Martins et al., 
2002).  
Taking ownership of their health and well-being gives people the opportunity to 
take responsibility for and build confidence in their ability to manage their own health 
status (Hughes et al., 2001). Patient empowerment helps patients to improve their levels 
of awareness and also supports the development of positive relationships with their 
physicians. Hughes et al. (2001) reported similar results in other studies indicating that 
patients found nonprescription or any OTC medication more convenient, effective, and 
economical. Hughes et al. collected data from the British Market Research Bureau 
International from approximately 2,000 people about their use of nonprescription 
medications. The data analysis indicated that 80% of the participants felt that it was 
important to use nonprescription medicines for minor health problems, 67% reported that 
such medicines were just as effective as those obtained from doctors, and 86% stated that 
they would purchase again the same medication that they had used previously. These 
results suggested that the public has confidence in self-treatment as well as the 
convenience and effectiveness of medications that are available without physicians’ 
prescriptions (Hughes et al., 2001).  
Approximately 60% to 80% of health problems in developing countries are now 
being treated through self-medication regimens (Auta et al., 2012). A cross-sectional 
survey of 1,000 Slovenian adults ages 18 years and older was conducted by Klemenc-
Ketis and Kersnik (2011) to gain insight into when the participants chose to self-
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medicate. The results showed that 77.2% of the participants chose to self-medicate when 
they first identified symptoms.  
Despite the convenience of purchasing OTC medications, the health care system 
cannot monitor these purchases effectively enough to impact patient care and OTC 
medication consumption. As a result, it has become challenging to collect data on the use 
of OTC medications such as NSAIDs because they are usually not reported or 
documented (Kovac, Saag, Curtis, & Allison, 2008). Most data on the consumption of 
OTC medications have been obtained from outside of the United States. Guirgis (2010), 
for example, conducted a retrospective cohort study of 51 patients in Australia to 
examine the prevalence of the consumption of OTC products by chronically ill patients. 
Guirgis found that 80% of the patients with chronic conditions used OTC products and 
did not follow the directions on the package inserts.  
Baig et al. (2012) conducted a quantitative, cross-sectional study to determine the 
prevalence of and factors associated with self-medication among 400 dental patients 
visiting an outpatient dental department from March to May 2010 at Fatima Memorial 
Hospital in Pakistan. The results gleaned from the questionnaire responses showed that 
the prevalence of self-medication was 70.8%, high in comparison to studies in China 
(32.5%), India (34.5%), and Turkey (45%), but low in comparison to studies in Sudan 
(73.9%) and Kuwait (92%; Baig et al., 2012). Furthermore, Baig et al. reported that 
66.4% of their participants who self-medicated were female.  
Solomon (2003) completed a study in Nigeria whose results showed a high 
prevalence of self-medication among female individuals (61.9%); Angeles (as cited in 
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Solomon, 2003) found the same results in a study in Mexico (46%). The level of 
education documented by Baig et al. (2012) showed that 28.4% of graduates self-
medicated. Of the participants who graduated, 57% stated that self-medication was an 
option as a treatment regimen to avoid unnecessary dental care, 40% considered cost in 
the decision to self-medicate, 55.6% self- medicated because of a lack of time, and 52% 
self-medicated because of a dental phobia (Baig et al., 2012). According to Afolabi 
(2012), individuals who have chronic conditions such as asthma will self-care for months 
and years, with 48% of these individuals buying OTC medications as a prophylaxis. 
Afolabi also reported that of the individuals known to have frequent migraines, 
approximately 42% will self-treat rather than seek treatment from their physicians and 
that in Canada, 90% of individuals suffering from migraines will use OTC medications.  
In most developing countries, self-care medications can be purchased without 
physicians’ prescriptions. For example, in Ecuador, 51% of medication sales are OTC, 
66.3% in the Philippines, and 80% across the United States-Mexico (Afolabi, 2012). In 
countries where OTC medications are regulated, the percentage of nonprescription sales 
is approximately 26.2% (Afolabi, 2012). Researchers have published very few studies 
evaluating the use of OTC medications and OTC NSAIDs specifically. Antonov and 
Isacson (1996) conducted a study in Sweden showing that the use of analgesics was 
common among people reporting chronic pain. Female participants who reported chronic 
pain consumed more analgesics and sedatives than the male participants did. Besides 
female gender, self-perceived poor health, high pain intensity, insomnia, physician 
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consultation, and self-care action helped to explain medication with analgesics (Antonov 
& Isacson, 1996). 
Factors That Determine Attitudes About Medications 
Self-care orientation and medication knowledge are important factors in 
determining attitudes toward the consumption of medications (Isacson & Bingefors, 
2002). There has been an ongoing increase in the number of people who are taking 
responsibility for their own health because of SES factors (e.g., empowerment over 
personal health, improved educational levels, and access to information); lifestyle 
choices; ready access to medications; increased potential to manage certain illnesses 
through self-care; public health and environmental factors; greater availability of 
medicinal products; and demographic and epidemiological factors (Baig et al., 2012; 
WHO, 1998). Taking responsibility also can depend on sociocultural and personal 
factors, which might help to explain why people have different reactions to illnesses and 
different ways of handling their self-medication (Klemenc-Ketis & Kersnik, 2011).  
However, if individuals do not take responsibility for their self-medication 
regimens, they are at risk of consequences that include, but are not limited to, bacterial 
resistance, masking of symptoms or illness that can delay treatment, and decreased 
efficacy of medications because of wrong dosages or duration (Balbuena et al., 2009). 
Furthermore, cultural and religious beliefs can sometimes create additional risks related 
to self-medication (Balbuena et al., 2009). In an observational, cross-sectional study of 
245 participants ages 65 years and older in Chiapus, Mexico, Balbuena et al. (2009) 
evaluated the consumption of OTC medications and additional factors that might have 
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affected the participants’ decisions to self-medicate. More than 50% of the participants 
consumed OTC medications within a 30-day period. Self-medication was significantly 
higher among the participants who lived independently than among the married couples  
(p = .0274) as well as those who were illiterate or had low educational levels than among 
participants with secondary school degrees (p = .0036); 26.7% of the participants 
reported adverse events.  
Other factors such as level of education and SES might impact individuals’ 
knowledge of OTC medications. Inequities in health care, including the consumption of 
OTC medications, continue to be a public health challenge (Hosseinpoor, Williams, Itani, 
& Chatterji, 2012). Globally, SES, as measured by education, income, or occupation, is 
associated with poorer health status (Hooseinpoor et al., 2012). Hosseinpoor et al. (2012) 
used the health domains of mobility, pain, sleep cognition, and vision developed by the 
WHO to assess SES inequalities in these domains and their relationship to self-care. In 
the study, self-care was defined as the care taken by individuals to enhance their own 
health, prevent disease, limit illness, and restore health and well-being. In practice, self-
care includes actions to stay fit and maintain good physical and mental health, meet 
social and psychological needs, prevent illness or accidents, avoid unnecessary risks, care 
and self-medicate for minor ailments and long-term conditions, and maintain health and 
well-being after an acute illness or discharge from hospital. The results showed that 
inequalities were related to level of income (Hosseinpoor et al., 2012).  
You et al. (2011) conducted a cross-sectional phone survey of approximately 
1,100 noninstitutionalized individuals in Hong Kong to determine their knowledge about 
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using OTC products. The results showed that participants who had no formal education 
or just a primary education (OR = 3.19; p < .001); had a secondary school education  
(OR = 1.50; p = .035); and were > 60 years of age (OR = 1.82; p = .042) were more 
likely to be less knowledgeable of self-medication and the risk factors associated with 
using OTC medications (You et al., 2011).   
OTC Medications and Lack of Medical Supervision 
OTC medications can be taken without the advice of pharmacists or doctors. They 
are commonly available, and their use is perceived as safe (Neafsey & Shellman, 2001). 
Health care authorities have encouraged the self-care of minor ailments to reduce the cost 
of medical care (Indermitte, Reber, Beutler, Bruppacher, & Hersberger, 2007), but the 
lack of supervision might increase the risk of adverse drug effects, including those caused 
by drug-drug interactions. Furthermore, unless patients receive support or guidance from 
physicians, their questions about the consumption of OTC medications and dietary 
supplements will remain unanswered (Haverhals et al., 2011; Hughes et al., 2001).  
Consumption of NSAIDs is an important patient safety concern. Self-medication 
drugs are not required to be monitored systematically and are usually not documented in 
people’s medication histories (Indermitte et al., 2007). The Joint Commission on National 
Patient Safety (as cited in Kovac et al., 2008) recommended obtaining and keeping a 
complete and up-to-date list of all patients’ medications in an effort to decrease adverse 
drug events. Despite the national goal of wanting to generate awareness to improve 
patient care, no data have documented improvements in communication between patients 
and physicians in regard to the appropriate consumption of NSAIDs. Indermitte et al. 
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(2007) suggested that because of the increased use of OTC medications, the U.S. federal 
government should consider initiating a policy to monitors patients’ self-medication 
behaviors to reduce the risk of adverse events that are otherwise preventable. 
Furthermore, no universal standardized system is in place to measure OTC NSAIDs 
consumption (Kovac et al., 2008). Because patients do not always consider 
nonprescription medications to be drugs, they often will not report their nonprescription 
drug use (i.e., OTC medications) to their physicians. In addition, physicians do not tend 
to include questions about the consumption of OTC medications during consultations 
with patients (Hughes et al., 2001).  
The quality of the physician-patient relationship and the level of communication 
between physicians and patients are related to patient outcomes (Ratanawongsa et al., 
2008). A higher quality of communication and trust can influence patient satisfaction, 
compliance, and recall of medical information. Communication also is linked to 
improved outcomes related to emotional health, functioning symptom resolution, and 
blood pressure and/or blood sugar control (Ratanawongsa et al., 2008).  
Trust refers to the expectation that people will behave in ways that are not 
harmful (Thom et al., 2011). For example, patients will share information with physicians 
when there is trust between them. A lack of trust also is likely to affect patients’ behavior 
and health outcomes (Thom et al., 2011). Ratanawongsa et al. (2008) discussed the 
importance of communication in the physician-patient relationship and its relationship to 
patient outcomes.  
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Other factors also can impact self-medication. A qualitative analysis of a series of 
individual and semistructured group interviews was completed by Haverhals et al. 
(2011), who studied five concepts related to the challenges of self-medication: reliable 
medication information, maintenance of autonomy in medication treatment decisions, 
polymedications, alternative therapies, and the tracking and coordination of health 
information among multiple providers. Haverhals et al. found that physicians were the 
least likely to be consulted by patients, even if timely responses were warranted, and that 
patients believed that physicians were too busy to address their medication information 
needs. In addition, patients preferred to make independent decisions so that they could 
remain in control of their treatment regimens. Patients also expressed concern about the 
consumption of multiple medications, but they had a tendency to remember only 
prescription medications and frequently not list supplements or nonprescription 
medications because they did not feel it necessary to discuss them with their physicians 
(Haverhals et al., 2011). This lack of communication might have been the result of a lack 
of trust between the patients and their physicians.  
 Sixty percent to 95% of medical issues are treated initially with self-care, 
including the use of OTC medications (Amoako, Campbell, & Malone, 2003). 
Approximately 100,000 OTC drugs are available to consumers, and their use continues to 
increase (Amoako et al., 2003). Over a 3-month period, Amoako et al. (2003) evaluated 
the use of nonprescription drugs among an elderly population between the ages of 59 and 
91 years who lived in a housing project in North Carolina. A survey with categories 
involving the consumption of OTC medications focused on the frequency of use, source 
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of information on OTC adverse drug reactions, demographic factors, perceived health, 
number of chronic diseases, and other interventions used concurrently with OTC 
medications was conducted. The results indicated that 90% of the participants used pain 
medication, 67% used at least one medication for blood pressure, 59% consumed caffeine 
on a daily basis, and 10% consumed alcohol (Amoako et al., 2003). These percentages 
showed that physicians should consider the need to improve communication skills with 
elderly patients to improve the patients’ safe use of OTC drugs. 
 The elderly cohort, that is, people ages 65 years and older, often choose to self- 
medicate. The Administration of Aging has estimated that by 2030, 72.1 million U.S. 
citizens will be in this age bracket (as cited in Taylor et al., 2011). According to Amoako 
et al. (2003), elderly individuals use OTC drugs to self-treat minor illnesses such as fever, 
runny nose, sore throat, cough, nausea, diarrhea, constipation, indigestion, headache, or 
muscle or joint pain approximately 69% to 85% of the time. A majority of the elderly 
population also use prescription and OTC NSAIDs. NSAIDs are the main class of 
medications used to treat chronic pain (Taylor et al., 2011).  
In 1992, Conn (as cited in Amoako et al., 2003) interviewed 185 adults ages 65 
years and older to determine their use and management of 16 common OTC medications 
and found that the respondents used almost twice as many OTC drugs as prescription 
medications. In 1996, Kriner (as cited in Amoako et al., 2003) conducted a telephone 
survey of 874 individuals ages 50 years and older to determine their prescription drug 
use. Sixty-nine percent of the participants ages 65 years and older were taking 
prescription medications, with an average of 2.4 prescription drugs/participant. More than 
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half (57%) of the participants indicated that no one reviewed their prescription and OTC 
medications the last time they received new prescriptions.  
Fraenkel, Wittink, Concato, and Fried (2004) conducted a study on prescribed 
NSAIDs medications. They reported that 54% of the patients who had osteoarthritis were 
unaware of NSAIDs toxicity and 80% were unaware of cyclooxygenase (COX)-2 
toxicity. These results were problematic because of the wide availability of OTC NSAIDs 
and the lack of patient communication with physicians about their use of OTC NSAIDs.  
The American College of Gastroenterology (as cited in Lanza, Chan, & Quigley, 
2009) reported that approximately 20% of the respondents in the study did not report 
their use of NSAIDs to their physicians; 22% did not believe that the medications were 
important enough to list or discuss; and 30% reported that because they were not 
prescribed medications, it was unimportant for their physicians to know about them. The 
responses reflected a common misconception that these medications are insignificant or 
benign; however, when used on a chronic basis, particularly among the elderly cohort, 
these medications can lead to serious and potentially fatal adverse events (Okura, Urban, 
& Mahoney, 2004). Adverse side effects of NSAIDs include gastrointestinal, 
cardiovascular, renal, and hematological problems (Taylor et al., 2011). Prescribing 
NSAIDs to elderly patients requires physicians to be knowledgeable and aware of 
individual patient risk factors, be able to assess the risk-benefit ratio, and take 
responsibility for educating patients and monitoring the effectiveness and side effects of 
this class of medications (Taylor et al., 2011). 
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OTC Medication Consumption and Communication With Physicians 
As mentioned previously, patients do not routinely discuss their OTC medication 
consumption with their own physicians or other physicians. In addition, patients’ racial or 
ethnic backgrounds can affect the quality of patient-physician communication during 
medical visits (R. Johnson, Roter, Powe, & Cooper, 2004). R. Johnson et al. (2004) used 
audiotaped interviews and questionnaires to look for any differences in the quality of 
medical visit communications between African American and European American 
patients in Baltimore, the District of Columbia, and Virginia. The results showed that 
physicians were more verbally dominant and less patient centered with African American 
patients than with European American patients. R. Johnson et al. suggested that this lack 
of patient-centered communication, including less patient input into the medical dialogue 
(i.e., building rapport), might be contributing to health care disparities or continuity of 
care.  
However, other studies on patient-physician communication have not focused 
specifically on the consumption of NSAIDs, an important patient safety concern. The 
Joint Commission recommended obtaining and keeping up-to-date lists of all patients’ 
medications in an effort to decrease adverse drug events (as cited in Kovac et al., 2008). 
Maintaining current lists of patients’ medications, prescription and OTC, might help to 
improve communication between patients and physicians about the appropriate 
consumption of NSAIDs.  
Torrible and Hogan (1997) examined the medications of 25 patients ages 75 years 
and older who lived in a rural area of southern Alberta. They obtained the information 
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from medical records and in-home interviews. The patients took an average of five or six 
prescribed medications and 3.5 OTC medications. The results showed that the family 
physicians and the primary dispensing pharmacists were aware of only some of their 
patients’ medication regimens (Torrible & Hogan, 1997). The researchers also found that 
these elderly patients often would misinform their health care providers about their use of 
medications.  
Lack of knowledge and poor communication are remediable reasons for the 
failure to achieve self-care. Before designing interventions to improve self-medication 
regimens, it is important to characterize self-medicating patterns within the community. 
Particularly in the elderly population, special attention is warranted because of the 
increased potential occurrence of adverse events.  
 It is common for people to choose OTC medications without the supervision of 
physicians. Self-medication might be an obstacle to patient care because of the lack of 
communication and safety (You et al., 2011), so it is important to understand why there 
are variations in the levels of self-care among individuals. The Self-Medicating Scale 
(SMS), developed and validated by James and French (2008), can be used to describe 
individuals’ self-medication beliefs and how they make decisions about self-treatment as 
a response to everyday symptoms.  
People tend to behave differently when they are ill (Klemenc-Ketis & Kersnik, 
2011). Encouraging self-care relies on the careful design of interventions to support 
positive health-seeking behavior (James & French, 2008). For instance, some people 
might choose to self-medicate at the first indication of discomfort, whereas other 
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individuals might choose to self-medicate after symptoms have developed further and 
they have reached their threshold of pain tolerance (James & French, 2008; Klemenc-
Ketis & Kersnik, 2011). As a result, it is important to understand individuals’ self-
medicating habits. Beliefs about dealing with illness and taking medications can 
influence health-related behaviors, including adherence to treatment regimens prescribed 
by physician as well as self-care that includes OTC medication choices (James & French, 
2008).  
Elderly individuals consume OTC medications for different reasons. For instance, 
NSAIDs or COX-2 selective inhibitors have become the preferred option to relieve pain 
and increase mobility (White, 2009). OTC analgesics include acetaminophen and 
NSAIDs such as ibuprofen, naproxen, and aspirin. NSAIDs, however, do not have a clean 
profile of side effects, even though many are safe enough to be purchased without 
prescriptions. This class of medication is the most common cause of reported adverse 
reactions, including gastrointestinal, cardiovascular, and renal problems (Sulaiman, 
Seung, & Ismail, 2012). 
NSAIDs can cause gastrointestinal complications (Tamer, Moore, Reynolds, & 
McQuay, 2000), so researchers have tended to focus their attention on these 
gastrointestinal side effects. For instance, Adams et al. (2011) reported that the rate of 
death from NSAIDs-related gastrointestinal complications is higher than that from 
cervical cancer, asthma, or malignant melanoma. They also reported that the incidence of 
gastrointestinal bleeding among people who are taking NSAIDs is .69%, compared with 
.002% for those not taking NSAIDs. Approximately 100,000 hospitalizations secondary 
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to NSAIDs-induced gastrointestinal complications occur annually, and approximately 
one of every 1,200 people consuming NSAIDs for more than 2 months will die from 
gastrointestinal complications (Breedveld, 2003). NSAIDs also increase blood pressure, 
placing people who consume NSAIDs for long periods at increased risk of thrombotic 
events such as cerebrovascular accidents and myocardial infarction (Mackenzie & 
MacDonald, 2010). 
 The Sloan Survey, which was conducted in the United States, found that more 
than twice as many people used acetaminophen (23%), ibuprofen (17%), or aspirin (17%) 
than any other OTC medications (as cited in McDonald et al., 2007). Similar results were 
reported in a survey conducted in Finland (as cited in McDonald et al., 2007), where 27% 
of the participants reported consuming OTC analgesics a few times each week (as cited in 
McDonald et al., 2007). The safe and effective use of OTC analgesics can decrease pain 
and improve functional status, but the unsafe and inappropriate consumption of OTC 
analgesics can result in serious and sometimes fatal consequences (McDonald et al., 
2007).  
McDonald et al. (2007) cited the Sloan Survey’s findings that 36% of the patients 
diagnosed with epigastric bleeds did not know that this bleeding is a common adverse 
event related to the consumption of NSAIDs and had experienced pain before their 
bleeding. However, only 11.1% of the patients discontinued their NSAIDs consumption. 
On the other hand, only 15% of the patients with epigastric bleeds who had been 
informed about adverse events reported experiencing pain before the bleeding, and 67% 
consequently decreased their NSAIDs consumption (McDonald et al., 2007). Prescribing 
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NSAIDs or using OTC NSAIDs involves knowing the individual risk factors to patients 
and assessing the risk-benefit ratio.  
 Adams et al. (2011) found that patients who had increased their consumption of 
NSAIDs were at increased risk of adverse events and also had been diagnosed with 
chronic conditions that contraindicated NSAIDs use. For instance, approximately 75% of 
the individuals in the study who consumed NSAIDs had one or more medical 
complications of cardiovascular disease, hypertension, or chronic renal failure. The use of 
NSAIDs in this patient population was not the result of self-medication OTC NSAIDs 
consumption, but of the result of treatment regimens directed by physicians that include 
prescriptions for NSAIDs (Adams et al., 2011).  
The incidence of adverse events related to prescribed NSAIDs emphasizes the 
importance of examining patterns of NSAIDs use by the elderly population. Patients’ 
attitudes and knowledge, as well as their willingness to ask their physicians questions, 
might have an impact on their levels of NSAIDs use. It is important for physicians to 
determine whether the use of NSAIDs continues because the users want relief, despite the 
risk of adverse events, or because they lack awareness of the potential adverse side 
effects of prescription and OTC NSAIDs.  
Timely access to care as well as diagnostic, preventative, and therapeutic services 
and modalities is not the only measure of the quality of health care received. Patient-
centered care and patient-physician communications might be aspects of racial and ethnic 
disparities. Patient-physician communication, for example, is an integral part of clinical 
practice. During health care visits with their patients, physicians must make choices about 
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the appropriate use of words, questions, silences, tone of voice, and facial expressions 
Because these choices can enhance or detract from the overall delivery of care.  
R. Johnson et al. (2004) collected data from 1998 to 2002 from 61 physicians in 
the District of Columbia and surrounding area to determine whether the quality of 
medical visits and visit communication was different for African American and European 
American patients. The results showed that patient engagement and participation rather 
than overall time spent with the physician could play a role in health care disparities. For 
instance, R. Johnson et al. reported that 23% of the physicians were more verbally 
dominant and engaged in 33% less patient-centered communication with African 
American than with European American patients. In 2002, van Wieringen, Harmsen, and 
Bruijnzeels noted that in the Netherlands, there was a decreased positive effect of medical 
visits made by racial or ethnic minority patients than by native-born Dutch patients.  
 Individuals might benefit from receiving information about prescription or OTC 
medications that can improve their safe use of OTC analgesics and avoid potential 
adverse events (McDonald et al., 2007). A pamphlet prepared several years ago by the 
FDA (as cited in McDonald et al., 2007) provides safety information about taking OTC 
analgesics. However, the pamphlet does not explain the potential interactions of NSAIDs 
and antihypertensive medications; the potential interactions of acetaminophen and 
alcohol; and the fact that taking more than the maximum recommended dose of NSAIDs 
provides no greater analgesia (i.e., ceiling effects). Perhaps if more information were 
added to the educational material, it would increase the safe use of OTC analgesics by 
consumers.  
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The purpose of the study by McDonald et al. (2007) was to test the effect of 
adding information to the FDA pamphlet on the safe administration of OTC analgesics.  
This study was a randomized, double-blind, posttest-only investigation with a sample of 
137 adults who evaluated the updated FDA pamphlet, which included the aforementioned 
additional safety information about OTC analgesics. The results were not positive and 
indicated that adding additional information about potential NSAIDs interactions with 
antihypertensive medications, the potential interaction of alcohol and acetaminophen, and 
NSAIDs ceiling effects did not impact the consumption of OTC analgesics. The results 
also highlighted that the mode of delivery of educational materials (i.e., written or verbal) 
can influence the recipients’ knowledge and awareness of NSAIDs. It is important that 
people be educated about the OTC analgesics that they plan to take so that they can make 
informed decisions about the relative risks and benefits (McDonald et al., 2007).  
Roumie and Griffin (2004) found that 33% of the 1,000 adults whom they 
surveyed took more than the recommended doses of their nonprescription medications 
because they felt that the extra doses would increase the effectiveness of the medications. 
Sulaiman et al. (2012) reported that success in patient therapy depends on patients’ 
choices of medication as well as their compliance. Drug information that physicians share 
with patients should include pharmacological properties, instructions for use, warnings as 
well as indication (Sulaiman et al., 2012).  
Twenty-one percent of the respondents in McDonald et al.’s (2007) study 
indicated that they would take a second dose before the recommended time, which meant 
that they were placing themselves at increased risk of adverse drug events. In addition to 
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the patients in the study who did not follow the recommended dosages, patients with past 
medical histories or current medical illnesses also were identified as being at increased 
risk of adverse drug events with certain OTC medications. For example, patients with 
poor renal function were identified as being at increased risk of kidney damage when 
taking NSAIDs, which also can interfere with antihypertensive medications by 
decreasing the effectiveness of the medications and impacting blood pressure levels 
(McDonald et al., 2007).  
McDonald et al.’s (2007) meta-analysis of 45 studies found a significantly 
increased risk of developing gastrointestinal complications when the participants took 
NSAIDs for 84 days or more; participants who took naproxen increased their risk of 
gastrointestinal complications by 1.83 times. In addition, McDonald et al. reported that a 
randomized-controlled clinical PAIN study conducted in France with 8,677 people 
compared acetaminophen, aspirin, and ibuprofen use for the frequency of adverse drug 
events. The results showed that a total of 1,347 (15.6%) of the participants experienced 
significant adverse events from taking NSAIDs. Aspirin had the highest incidence of 
adverse events, but the incidence of adverse events was similar for acetaminophen and 
ibuprofen (McDonald et al., 2007).  
The annual report of the American Association of Poison Control Center National 
Poison Data System (as cited in Hunter, Wood, & Dargan, 2011) indicated that analgesics 
are the most common category of drug in acute overdose in adult patients (10%) and the 
second most common in pediatric patients (9%). Acetaminophen consumed 
independently or as an ingredient in other medications was identified as the most 
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common analgesic in an acute overdose (42%), with NSAIDs contributing to 33% of 
reported analgesic acute ingestions. Ibuprofen was the most common NSAIDs taken in 
overdose (81%), followed by naproxen (11%; as cited in Hunter et al., 2011).  
Neafsey et al. (2002) published many studies on the use of OTC NSAIDs. 
Neafsey et al. found that elderly patients who presented at clinics for blood pressure were 
at increased risk of adverse drug reactions because of their decisions to self-medicate or 
because their knowledge of potential interactions from self-medication practices was low. 
Neafsey et al. also studied the use of a computerized personal education program to 
educate residents in seniors’ centers in rural New England about possible drug 
interactions when self-dosing with OTC medications and consuming alcohol. The results 
showed an increase in the treatment group’s level of knowledge of potential interactions 
of prescription medications with OTC medications and alcohol compared to that of the 
control group (Neafsey et al., 2002).  
 The results of Neafsey et al.’s (2002) study were not confounded based upon age 
and level of education, suggesting that this electronic program was effective. Future 
studies involving the use of this personal education program might be beneficial with 
individuals of lower education levels to help to remove the barriers of advanced age and 
limited education in health literacy efforts (Neafsey et al., 2002). Education is a key 
component in efforts to modify OTC medication practices.  
Another study at the Rheumatology Clinic in Northern Malaysia included patients 
18 years of age and older (Sulaiman et al., 2012). The purpose of the study was to 
demonstrate that educating patients about prescription NSAIDs use could result in greater 
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patient satisfaction. Sulaiman et al. (2012) found that the low SES, education, and 
literacy levels of some patients were factors affecting the use of prescription medications. 
The results highlighted the importance of providing guidance and knowledge to patients 
about the consumption of prescription medications as well as the need to gain a better 
understanding of the elderly population’s levels of consumption of OTC NSAIDs. Drug 
information that is shared with patients should include pharmacological properties, 
instructions for use, warnings, and potential contraindications about consumption 
(Sulaiman et al., 2012).  
  The results of Neafsey et al.’s (2002) study cannot be generalized to the entire 
population of older adults because the participants in their study were mostly European 
American females and the sample was not large enough to compare the effectiveness of 
race versus gender. The personal education program was being studied on a larger scale 
in two racially and economically diverse urban communities. The results of Neafsey et 
al.’s study will help to determine whether educational programs are equally effective with 
males and females, along with European Americans, African Americans, and English-
speaking Latino Americans. The implication for future practice is that the delivery of 
health information to older adults via computers equipped with touch screens has the 
potential to revolutionize the delivery of public health education by community nurses 
and other allied health professionals. 
 The appropriate consumption of medications may help to decrease the rates of 
adverse events and premature death (Taylor et al., 2011). In 2001, more than 4 million 
people had adverse events secondary to taking medications inappropriately (Taylor et al., 
44 
 
2011). According to reports from the Institute of Medicine (as cited in Taylor et al., 
2011), approximately 1.5 million of adverse events can be prevented and that 50% of 
preventions will happen if physicians change their prescribing regimens and know what 
other types of medications, including OTC drugs, their patients are taking. Taylor et al. 
(2011) evaluated 807 NSAIDs users and found that 54% of the participants did not know 
the side effects associated with this class of medication, 33% believed that prescription 
NSAIDs are safer, 32% believed that OTC NSAIDs are safer, 20% believed that there is 
no difference, and 15% did not know. Sixty-percent of the participants, as well as 29% 
who were exclusive OTC NSAIDs users, were neither aware of nor believed that they 
were at risk of side effects from consuming NSAIDs.  
 In addition to the decreased awareness of side effects when taking one of the 
NSAIDs, patients also were unaware of the side effects of taking multiple NSAIDs or 
taking NSAIDs for extended periods (Taylor et al., 2011). Taylor et al (2011) studied 
patients with chronic pain and their knowledge of the risks of taking prescribed NSAIDs 
and OTC NSAIDs. Forty-nine percent knew that taking multiple NSAIDs increased the 
risk of side effects, 41% were uncertain, and 10% did not believe that there were any 
risks. Physicians need to educate their patients in an effort to improve their awareness.  
 Trelle et al. (2011) completed a meta-analysis of the cardiovascular safety of 
seven prescription NSAIDs (naproxen, ibuprofen, diclofenac, celecoxib, etoricoxib, 
rofecoxib, or lumiracoxib) and a placebo. The primary endpoint looked at the rates of 
myocardial infarction, and the secondary endpoints included stroke death from 
cardiovascular disease and death from any other cause (Trelle et al., 2011). When 
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comparing the NSAIDs to a placebo, rofecoxib was associated with the highest risk of 
myocardial infarction, followed by lumiracoxib. Ibuprofen was associated with the 
highest risk of stroke, followed by diclofenac. Etoricoxib and diclofenac were associated 
with the highest risk of cardiovascular death (Trelle et al., 2011).  
Data from the Health Improvement Network (nested case-control study) of 8,852 
people between the ages of 50 and 84 years were analyzed by Rodriguez, Tacconelli, and 
Patrignani (2008) to determine whether there was an association between prescription 
NSAIDs and the risk of nonfatal myocardial infarction. The results showed that the risk 
of myocardial infarction varied, depending upon the type of NSAIDs consumed and the 
extent of COX-2 inhibition. For NSAIDs with a degree of COX-2 inhibition < 90%, the 
RR was 1.18, whereas NSAIDs with a greater COX-2 inhibition had an RR of 1.60. The 
data also exhibited an increased risk of myocardial infarction, depending upon treatment 
duration and daily dose (Rodriguez et al., 2008).  
Fosbol et al. (2010) looked at the cardiovascular risk of healthy individuals in 
Denmark who used NSAIDs. This population-based, historic cohort study was conducted 
to examine specific cardiovascular risk (i.e., morbidity and mortality) in relation to 
treatment with and patient consumption of NSAIDs. The results showed that NSAIDs 
have different degrees of risk concerning cardiovascular morbidity and mortality.  
 According to van Staa, Rietbrock, Setakis, and Leufkens (2008), the longer that 
patients use NSAIDs, the greater is the risk of myocardial infarction, a risk that continues 
for years after the cessation of NSAIDs use. This increased risk, even after NSAIDs use 
has stopped, could be the result of the initiation of alternative medications that could 
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increase the risk of myocardial infarction (van Staa et al., 2008). There also has been a 
gap in understanding whether the side effects of NSAIDs might continue for years after 
therapy has stopped (van Staa et al., 2008). The results of the study were consistent with 
other epidemiological studies in showing that the relative risk of myocardial infarction 
was strongly associated with NSAIDs exposure and that the risk was the lowest among 
patients who used NSAIDs over the short term or intermittently and the highest among 
patients who consumed NSAIDs over the long term and every day. 
  Van Staa et al. (2008) also looked at different NSAIDs (diclofenac, ibuprofen, 
and naproxen) and found that the risk of myocardial infarction was the same for all of 
them. However, looking back at other observational studies, van Staa et al. found that the 
relative risk of myocardial infarction based upon the NSAIDs used was 1.40 for 
diclofenac, 1.07 for ibuprofen, and .97 for naproxen.  
International guidelines discourage NSAIDs treatment of patients with established 
cardiovascular disease; however, if such a treatment regimen cannot be avoided, the 
duration of NSAIDs use should be as short as possible (Olsen et al., 2011). According to 
Olsen et al. (2011), only a few researchers have looked at time to event for NSAIDs 
treatment, and the results have identified an increased risk at the initiation of therapy that 
continues until the cessation of treatment. Two randomized studies were designed 
specifically to determine the cardiovascular safety of NSAIDs treatment. Olsen et al. used 
the Danish National Patient Registry to determine whether the duration of NSAIDs 
treatment affected the cardiovascular risk in patients after myocardial infarction. The 
main results showed that the risks of death and death regarding myocardial infarction 
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were independent of the duration of NSAIDs treatment and that the risk of some NSAIDs 
became apparent immediately (diclofenac) or early (rofecoxib and ibuprofen) and after 
onset. The results supported past research indicating that patients with previous 
myocardial infarction are at increased risk when taking NSAIDs, especially diclofenac 
and selective COX-2 inhibitors. 
 NSAIDs help to control inflammation and pain, especially among the elderly 
population, but they also cause gastrointestinal complications. Atrial fibrillation is a 
common rhythm disorder among the elderly population (Schmidt, Christiansen, Mehnert, 
Rothman, & Sorensen, 2011) that is associated with morbidity and mortality. The use of 
NSAIDs might increase the risk of atrial fibrillation because of adverse renal 
complications that include fluid retention, electrolyte disturbances, and blood pressure 
destabilization. Schmidt et al. (2011) used the Danish National Registry of Patients to 
evaluate atrial fibrillation patients and assess NSAIDs use. The results showed that 
patients starting treatment with nonaspirin NSAIDs were at more risk than patients not 
using NSAIDs of atrial fibrillation or flutter. The relative increase was 40% to 70% (the 
lowest for nonselective NSAIDs and the highest for COX-2 inhibitors) and was the 
greatest among the elderly population. When physicians are prescribing NSAIDs, they 
need to identify atrial fibrillation or flutter as potential cardiovascular risks (Schmidt et 
al., 2011).  
Theoretical Framework 
Preventative health care behavior is associated with an expectancy-value 
approach. Expectancy refers to individuals’ beliefs about how well they can perform 
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tasks or activities, and value refers to incentives or reasons for performing tasks or 
activities (Ng, Kankanhalli, & Xu, 2009). Attitudes toward specific behaviors are a 
function of individuals’ perceived likelihood of outcomes associated with the behaviors 
and the expected values or evaluations of those outcomes (Ng et al., 2009). The 
expectancy-value model is the building block of the HBM, which posits that individuals’ 
behaviors can be explained by attitudes and beliefs (Boskey, 2008), that is, the values that 
they place on particular goals and the likelihood that given actions will achieve those 
goals (Galvin, 1992).  
The HBM is a social cognition framework used by researchers to study health 
behaviors (Hochbaum, 1958; Shanks, 2009; Thompson & Caltabiano, 2010). This model 
includes elements of individuals’ perceptions or beliefs influencing whether or not they 
will initiate health actions to avoid or prevent disease or illness (Hochbaum, 1958; 
Shanks, 2009; Thompson & Caltabiano, 2010). The HBM takes into account different 
perceptions that include perceived susceptibility of acquiring a health condition, 
perceived severity of the condition and its consequences, perceived barriers to engaging 
in the recommended behavior, perceived benefits of engaging in the recommended 
behavior, and perceived costs of engaging in the recommended behavior (Shanks, 2009; 
Thompson & Caltabiano, 2010). The HBM assumes that people are more likely to engage 
in disease prevention behaviors if they perceive that they are highly susceptible to the 
disease, the disease is serious, the behaviors are beneficial, the behaviors have few 
barriers, and they are cued to perform the behaviors (Chen et al., 2011; Guvenc, Akyuz, 
& Acikel, 2010).  
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To make informed choices, patients must be knowledgeable of the benefits and 
risks of medication. Knowing the safety aspects of medicine use is important to prevent 
poor health outcomes. I chose the HBM as the framework for this study because previous 
use of this model has shown it to be effective in identifying individuals’ readiness to 
engage in health behaviors initiated by a perceived threat of disease, the perception of 
susceptibility to disease, perceived potential severity, and perceived benefits and barriers 
(Glanz et al., 2002; Hochbaum, 1958). I also examined differences in perceived severity 
or adverse events resulting from OTC NSAIDs use and perceived susceptibility of 
adverse events resulting from consumption. 
Research based upon the HBM has typically considered the effect of demographic 
variables, personality, perceived efficacy, motivation, perceived threat, and external 
influences on the beliefs that guide individuals to make the right choices. For example, 
understanding individuals’ beliefs about their medical conditions and treatment regimens 
can be an opportunity to impact their adherence to drug treatment (Mann, Ponieman, 
Leventhal, & Halm, 2009). In a meta-analysis of 26 studies, Mann et al. (2009) found that 
psychological factors such as emotional stability, internal and external motivations, 
perceived benefit, and supportive structure are associated with better adherence to 
treatment medications. One incentive for individuals to participate in behavioral changes 
is the level of importance that they place on such modifying factors as body symptoms, 
media attention, illness of another person, postcard reminder of an appointment, or advice 
from others (Shanks, 2009). Additional modifying factors that can trigger behavioral 
changes include demographic variables (e.g., age, race, gender, or SES); 
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sociopsychological variables (e.g., social support, depression, or anxiety); and structural 
variables (e.g., knowledge about a disease or prior experience with the disease; Shanks, 
2009).  
  The theoretical foundation of the HBM suggests that people will not engage in 
behavioral changes unless they perceive that they are at risk of a disease or an illness and 
need to act (Hazaveshei, Taghdisi, & Saidi, 2007). The HBM was the theoretical 
framework of this study, which was conducted in an effort to help to prevent adverse 
events resulting from the inappropriate consumption of OTC NSAIDs. The HBM has 
three components: individual perceptions, modifying factors, and variables likely to 
affect initiating action. Individual perceptions include perceived susceptibility, perceived 
seriousness or severity, and perceived threat. Modifying factors are the factors that 
modify perceptions of a health action and encompass demographic variables (e.g., age, 
gender, etc.); sociopsychological variables, that is, the influence of peers or other 
reference groups that encourage preventive health behaviors, despite low motivation; 
structural variables, or knowledge of the target disease and prior contact with it; and cues 
to action, either internal or external (Galvin, 1992; Thompson & Caltabiano, 2010). The 
last component is likelihood to take action, which is the probability of taking the 
recommended preventive health actions, depending on the perceived benefits of the 
actions minus the perceived barriers, impediments, or obstacles to adopting the actions 
(Galvin, 1992; Thompson & Caltabiano, 2010).  
The HBM posits that readiness to engage in health behaviors is initiated by a 
perceived threat of a disease; perception of susceptibility to the disease; and the potential 
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severity, benefits, and barriers (Galvin, 1992; Thompson & Caltabiano, 2010). Perceived 
susceptibility refers to the subjective perception of the likelihood of experiencing health 
complication/s or conditions (Shanks, 2009). Perceived severity represents the associated 
feelings about the seriousness in terms of health (i.e., disability or death) and social 
consequences (i.e., job or family; Shanks, 2009). The level of perceived threat also might 
be based upon other variables, including knowledge. Perceived benefits refer to beliefs 
about the effectiveness of particular actions in decreasing threats to health (Shanks, 
2009).  
  According to the HBM, perceiving health complications or conditions as threats 
drive individuals to make behavioral changes; however, specific preventative behavioral 
changes might depend on the effectiveness of the tools available that can help to decrease 
such threats. Perceived barriers are the potentially negative obstacles that might 
discourage behavioral changes. These barriers can include behaviors that are time-
consuming, inconvenient, or expensive endeavors.  
The HBM shows that individuals will weigh the effectiveness of behavioral 
change against the barriers before engaging in the behaviors. When the benefits of 
behavioral change outweigh the barriers, individuals will be motivated to engage in 
actions that will demonstrate change (Thompson & Caltabiano, 2010). In addition, 
modifying factors might influence individuals to engage in behavioral changes that 
include cues to action and self-efficacy (Noroozi et al., 2011).  
Self-efficacy refers to the confidence to participate in behavioral change (Noroozi 
et al., 2011). Increasing individuals’ awareness of their risk of a disease or a condition 
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also might influence their readiness for change (Lopez & McMahan, 2007). Overall, the 
HBM suggests that people will be more motivated to make healthier choices if they 
believe that they are susceptible to particular negative health outcomes (Carpenter, 2010). 
People will not act to prevent negative health outcomes if they believe that the chances of 
their being affected by such outcomes are minimal (Carpenter, 2010). The stronger that 
people’s perceptions of the severity of negative health outcomes are, the more motivated 
they become to act upon behavioral changes to avoid such outcomes. However, if they 
perceive that the health outcomes will not have an impact on their lives, they will be less 
likely to embrace any changes (Carpenter, 2010). 
The HBM is appropriate for different populations and a variety of conditions or 
illnesses. The HBM helps researchers to understand behaviors and to answer questions 
about health conditions and illnesses concerning the intent to change behaviors. In the 
current study, changing individuals’ behaviors toward the consumption of OTC NSAIDs 
was considered important and beneficial to their health status and quality of life. This 
behavioral change needs to be viewed as a positive health behavior. When developing 
and implementing interventions to facilitate this behavioral change, it is important to 
recognize and identify individuals’ beliefs and the barriers that they will face when 
making such a change. I used the HBM to identify individuals’ decisions to adopt 
behavioral change in regard to excessive consumption of OTC NSAIDs in response to the 
threat of illness, that is, the participants’ perceptions of illness threat and evaluation of 
behaviors to resolve this threat. 
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Because perceived susceptibility associated with specific behaviors can vary 
among a population, it is necessary to understand the perceived susceptibility to and 
seriousness of adverse events related to an increased consumption of OTC NSAIDs 
because of the increased risk of uncontrolled blood pressure, gastrointestinal 
complications, and kidney failure. Perceived susceptibility focuses on individuals’ 
knowledge and belief of the ways that behavioral change can impact their lives. In the 
HBM, perceived benefits refer to individuals’ beliefs about the relative effectiveness of 
actions to reduce the threat of disease. Beliefs about the availability and effectiveness of 
various courses of actions, not the objective facts about the benefits, determine health 
behaviors. I focused on perceived benefits regarding on how elderly individuals (i.e., ≥ 
65 years) will adapt to new healthy behaviors and how this belief will help to decrease 
the likelihood of preventable adverse events.  
The perceived severity of an illness initiates the need for individuals to make 
changes to their lifestyles; however, people often are faced with barriers to make changes 
that can include a lack of education or knowledge, lack of awareness, and lack of 
communication with their physicians. Although people might believe that given actions 
are effective in reducing threats to their health, they also might find these actions 
inconvenient or unpleasant. Health care actions might not occur unless precipitating 
actions (i.e., cues to action) set the process in motion. Examples of cues to action include 
internal perceptions of symptoms, impact of the media, knowledge of others who might 
be experiencing similar diseases, or reminders by physicians. The results of this study 
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might lead to an increase in individuals’ health consciousness and willingness to engage 
in more preventative health care behaviors.  
Summary 
Included in this chapter was a discussion of self-care, the engagement in activities 
that are learned and are meant to promote healthy functioning based upon beliefs; health 
status; and sociodemographic characteristics (e.g., age, gender, culture, education and 
marital status) and traits (Fredericks & Sidani, 2012). As a part of self-care regimens, 
some individuals choose to self-medicate to treat self-recognized illnesses or symptoms. 
Afolabi et al. (2012) estimated that approximately 50% to 75% of health care is 
associated with self-medication. People who choose to self-medicate must be sure that 
the medication is appropriate for their chronic or recurrent condition and has proven 
characteristics of safety, quality, and efficacy (WHO, 1998).  
  Globally, people regularly consume OTC NSAIDs, medications that are available 
to consumers without physicians’ prescriptions. Individuals who consume these 
medications frequently or chronically are at increased risk of adverse events that might be 
the result of a lack of supervision that can lead to inappropriate dosing regimens, 
increased consumption rates, and drug-drug interactions. Because people might not be 
aware of the risk of misusing OTC NSAIDs, the risk to patient safety has become a 
concern. Lack of knowledge of potential side effects, along with variances in self-
medication, can be prevented. Disseminating information through health care 
professionals by opening the lines of communication between patients and physicians 
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might help to decrease adverse events and reveal more appropriate and effective ways to 
influence attitudes and behaviors.  
 Included in Chapter 3 is a description of the research design used to study the 
awareness of the elderly population of the risks associated with OTC NSAIDs 
consumption. Also presented are descriptions of the sampling procedures, eligibility 
criteria, instrumentation, data analysis, and protection of human participants.  
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Chapter 3: Methodology 
The main purpose of the study was to examine the association between the use of 
OTC NSAIDs by elderly individuals and their awareness of the risks associated with such 
use. The study also was conducted to assess the participants’ awareness of the risk of  
(a) adverse events associated with OTC NSAIDs use and OTC NSAIDs consumption,  
(b) adverse effects of OTC NSAIDs related to sociodemographic characteristics, and  
(c) adverse events and patient-physician levels of communication.  
The study was guided by three research questions and their hypotheses: 
1. To what extent does the awareness of the risk of adverse events associated 
with OTC NSAIDs use vary by sociodemographic characteristics among the 
elderly (SES, race/ethnicity, gender, and education)? 
H01: There is no significant difference between awareness of the risk of adverse 
events associated with OTC NSAIDs use and sociodemographic 
characteristics among the elderly population. 
Ha1: There is a significant difference between awareness of the risk of adverse 
events associated with OTC NSAIDs use and sociodemographic 
characteristics among the elderly population. 
2. To what extent does awareness of the risk of adverse events associated with 
OTC NSAIDs consumption vary by rates of OTC NSAIDs consumption 
among the elderly population? 
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H02: There is no significant difference between awareness of the risk of adverse 
events associated with OTC NSAIDs consumption among the elderly 
population. 
Ha2: There is a significant difference between awareness of the risk of adverse 
events associated with OTC NSAIDs consumption among the elderly 
population. 
3. To what extent are levels of awareness of adverse events associated with OTC 
NSAIDs consumption and levels of communication with their physicians 
among the elderly population? 
H03: There is no significant difference between awareness of adverse events 
associated with OTC NSAIDs consumption and the level of communication 
with physicians among the elderly population. 
Ha3: There is a significant difference between awareness of adverse events 
associated with OTC NSAIDs consumption and the level of communication 
with physicians among the elderly population. 
The results might help to fill the gap in the literature regarding the elderly 
population’s awareness of adverse events associated with the use of OTC NSAIDs. This 
chapter includes a discussion of the research design, instrumentation, sampling method, 
inclusion criteria, data analysis, and ethical considerations. 
Research Design 
I conducted a quantitative study with a cross-sectional design to gather data from 
a sample of elderly individuals in a metropolitan area in the Midwestern United States. 
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The data were collected from self-administered questionnaires (paper-and-pencil style) 
regarding medication use; attitudes and beliefs about the use of OTC NSAIDs; 
communication with health care providers; and sociodemographic characteristics (gender, 
race, SES, level of education, marital status, and living arrangements). A cross-sectional 
study design was appropriate for this study because all of the data on each of the 
independent and dependent variables were collected at one time. The paper-and-pencil 
style of questionnaire also was an easy and cost-effective way to collect the data. The 
information gained by using a cross-sectional study design helped me to assess the health 
needs of the elderly population, which will provide the medical community with 
information to consider developing and implementing educational programs as well as 
allocate health resources.  
Sample Selection 
 Purposive sampling was used to select the participants. Purposive samples are a 
nonrepresentative subset of the larger target population and depend upon the judgment of 
researchers in regard to their selection (Gregg, 2008; Issel, 2009). When using this type 
of sampling method, the focus is on a particular group, and predefined criteria determine 
the location of data collection and the number of participants to be recruited (Crosby, 
DiClemente, & Salazar, 2006; Gregg, 2008). The sample comprised elderly residents 
ages 65 years and older at the time of the study from a metropolitan area in the 
Midwestern United States. Exclusion criteria included being under the age of 65 years at 
the time of the study and not being able to answer the survey because of psychiatric, 
medical, or traumatic illness, or language barriers.  
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Participant recruitment occurred at two senior citizen community centers in the 
metropolitan area. Memberships at both centers comprise diverse populations. The 
centers provide appropriate quality recreational and nutritional services to the elderly 
population within their communities. Both centers gave me permission to collect data.  
Sample Size 
 To determine the sample size needed to answer Research Question 1, I used an a 
priori sample size calculation for a multiple regression model, G*Power 3.1 software 
program (Faul, Erdfelder, Buchner, & Lang, 2009). Using 10 independent variables (age, 
sex, ethnicity, marital status, education level, SES, living arrangements, status of having a 
physician, consumption of OTC NSAIDs, and communication) based upon a medium 
effect size (f2 = .15) and an alpha level of .05, the sample size required to achieve 
sufficient power (.80) was 118 respondents. A limited number of quantitative studies 
have examined the variables of interest among this population, so precise estimates of 
effect size could not be used. I selected the aforementioned parameters based upon the 
expectations of a medium effect and the need to reduce a Type I error.  
Recruitment Strategy 
 As mentioned previously, the participants were recruited from senior citizen 
community centers in a metropolitan area in the Midwestern United States. Once 
approval was obtained from Walden University’s Institutional Review Board (IRB 
approval #10-18-13-0169502), I worked with both centers to schedule recruitment dates 
and location. Once the dates were established, I posted an announcement in the 
newsletter for each community center indicating the date and location of the recruitment 
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process. The announcement also included a brief description of the study. On the 
recruitment date, I sat at a table and provided copies of the survey to interested 
individuals for them to complete.  
Instrumentation 
 To understand the participants’ levels of awareness and knowledge of the 
consumption of OTC NSAIDs, I asked the participants to complete a paper-and-pencil 
survey that was a composite of two validated instruments, the Perceived Efficacy in 
Patient-Physician Interaction Questionnaire (Maly et al., 1998) and the OTC Pain 
Reliever Survey (Cham et al., 2002). Permission to use these instruments was granted 
(see Appendix B).  
Perceived Efficacy in Patient-Physician Interaction Questionnaire. This 
instrument assesses patient-physician communication using a 10-point Likert scale 
ranging from 1 (no confidence) to 10 (very confident). The scores range from a minimum 
of 10 to a maximum of 100, the highest patient-perceived efficacy (Maly et al., 1998). 
The survey held 10 questions to determine levels of patient-physician communication 
related to understanding the information provided to patients, communicating information 
from patient to physician, and patients being able to have their physicians address and act 
on their medical issues (Maly et al., 1998). Each question began with the wording, “How 
confident are you in your ability to …?” (Maly et al., 1998). Although there have been no 
published estimates of reliability and validity of the tool, Maly stated that “its reliability 
in repeated studies since its original publication has demonstrated Cronbach’s alphas in 
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excess of .90 consistently and its construct validity has remained solid” (personal 
communication, April 16, 2003).  
  OTC Pain Reliever Survey. This instrument is used to assess the use of OTC 
medications. Components of the instrument facilitated the collection of demographic 
information as well as additional health information in the current study to assess how 
these variables might have impacted the participants’ awareness of the consumption of 
OTC NSAIDs. Responses to the survey were dichotomized to simplify the instrument. 
There have been no additional publications using Cham et al.’s (2002) questionnaire to 
demonstrate the validity and reliability of the instrument.  
Pilot Test 
The questionnaire used to collect the data was a combination of the two 
aforementioned survey instruments. The tool was precise and comprehensive. Prior to 
administering the survey, I pilot tested it with 12 participants who were not included in 
the full  study to assess its reliability and validity. The results were then analyzed for 
reliability and validity. I revised the final instrument as needed based upon the results of 
the pilot test.  
Data Collection 
 I introduced myself to potential participants as they voluntarily approached the 
table at each community center and then explained the objective, methods, and design of 
the study to them. Potential participants were screened to determine their eligibility to 
join the study. Individuals not eligible to participate received an explanation for that 
determination. Eligible participants received information regarding confidentiality and 
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voluntarily signed the informed consent form before receiving the packet, which included 
a cover letter and the questionnaire. This way, I could retain the consent forms and 
surveys separately. The procedure was the same at both senior citizen community 
centers: The participants completed the self-administered survey on site at both 
community centers, and I was present to answer questions or provide assistance. The 
term Caucasian was used to reflect the wording in the survey. The participants did not 
receive any compensation for being in the study. 
Data Analysis 
I analyzed the data using SPSS. The statistical analysis of the data helped to 
answer the three research questions. Table 1 presents the research questions, the relevant 
survey items to address each question, and the statistical test used. The variables that 
were used in these multiple regression calculations were age, sex, ethnicity, marital 
status, level of education, living arrangements, SES (level of income), presence of 
primary care physician, level of physician-patient communication, and consumption of 
OTC NSAIDs. 
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Table 1 
Research Questions and Statistical Test 
Research questions Survey items Statistical test 
1. To what extent does the awareness of the risk of adverse 
events associated with OTC NSAIDs use vary by 
sociodemographic characteristics among the elderly (SES, 
race/ethnicity, gender, and education)? 
Awareness scale  
(Items 14-22) 
Sociodemographic  
(Items 1-8) 
Multiple 
linear 
regression 
 
2. To what extent does awareness of the risk of adverse events 
associated with OTC NSAIDs consumption vary by rates of 
OTC NSAIDs consumption among the elderly population? 
 
Awareness scale  
(Items 14-22) 
Rate of consumption  
(Items 9-13) 
Multiple 
linear 
regression 
3. To what extent are levels of awareness of adverse events 
associated with OTC NSAIDs consumption and levels of 
communication with their physicians among the elderly 
population? 
Awareness scale  
(Items 14-22) 
Communication score 
(Items 23-32) 
Multiple 
linear 
regression 
 
Protection of Participants’ Rights 
I adhered to Walden University’s IRB guidelines to ensure the confidentiality and 
privacy of all information, as well as the participants’ individual rights. As mentioned 
previously, no data were collected prior to receiving approval from Walden University’s 
IRB. Participants received and signed the informed consent prior to completing the 
questionnaire. The informed consent also included information about the purpose and 
benefits of the study to the elderly community. No identifying information was collected, 
and the participants were advised that they had the right to withdraw from the study at 
any time. The responses were anonymous, and I stored the survey and the consent forms 
separately. I kept all data in a locked and secure location accessible to no one else other 
than myself. The questionnaire did not pose any risk of harm to anyone who voluntarily 
chose to participate in the study.  
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Summary 
 Included in Chapter 3 was an explanation of the cross-sectional study design used 
to conduct the research. This chapter also provided information about the research design, 
sampling plan, recruitment strategy, and data collection and data analysis procedures. The 
chapter concluded with a summary of the ethical considerations relevant to the study. 
Chapter 4 explains the results of the data collection and analysis processes. 
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Chapter 4: Results 
The purpose of this study was to determine (a) whether patients are aware of the 
risks associated with the consumption of OTC NSAIDs, and (b) whether there are 
differences in awareness based upon specific demographic characteristics. In addition, the 
study sought to identify the extent to which patient-physician communication levels 
influence patients’ awareness of adverse events. Responses from 124 participants were 
collected for this study. This chapter explains the results gleaned from the data collection 
and analysis. Study participant demographic characteristics and an assessment of the 
research questions also are presented.  
As mentioned in Chapter 3, I conducted a pilot study to ensure that the survey 
comprised a combination of two validated instruments. Prior to administration of the full 
survey, I had 12 participants assess the instrument to assess its reliability and validity. 
The results were analyzed for reliability and validity. The final instrument did not need to 
be revised based upon the results of the pilot test. Table 2 displays the psychometric 
characteristics for the three summated scale scores using the pilot study data (N = 12). 
Cronbach’s alpha reliability coefficients were as follows: communication (α = .89), 
awareness (α = .74), and consumption (α = .97). All three scales had adequate levels of 
internal reliability.  
Table 2 
 
Psychometric Characteristics for the Summated Scale Scores From Pilot Study  
 
Scale score No. of items M SD Low High α 
Communication 10 8.28 1.87 4.20 10.00 .89 
Awareness 7 3.33 2.06 0.00 6.00 .74 
Consumption 4 0.00 0.95 -1.03 1.50 .97 
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Sample Demographics 
Ages of the respondents ranged from 65 to 97 years (M = 76.1, SD = 7.52). About 
three quarters of the participants (n = 94, 75.8%) were female, and almost all  
(n = 120, 96.8%) were Caucasian. About one third (n = 43, 34.7%) of the participants 
were married, and another 46.8% (n = 58) reported being widowed. Sixty-one percent  
(n = 75) of the participants had attended at least some college courses, with 25.0% (n = 
31) having earned a college degree. Almost all (n = 122, 98.4%) of the participants had a 
primary care doctor, and about half (n = 64, 51.6%) lived alone. For the 101 participants 
who answered the income question, 86.1% (n = 87) reported an annual income of less 
than $50,000. Table 3 displays the frequency counts for the selected variables.  
Table 3 
 
Frequency Counts of Selected Variables Associated With NSAIDs Use  
 
Variable Category Frequency % 
Age rangea    
 65-69 25 20.2 
 70-79 61 49.2 
 80- 89 34 27.4 
 90-97 4 3.2 
Gender    
 Male 30 24.2 
 Female 94 75.8 
Race/Ethnicity    
 Caucasian/White 120 96.8 
 Other 4 3.2 
Marital status    
 Married 43 34.7 
 Widowed 58 46.8 
 Single 7 5.6 
 Divorced/Separated 16 12.9 
Education    
 Less than high school 8 6.5 
 High school graduate 41 33.1 
 Some college 44 35.5 
 College graduate 16 12.9 
 Graduate degree 15 12.1 
Table 3 Cont’d 
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Variable Category Frequency % 
 
Primary care doctor    
 No 2 1.6 
 Yes 122 98.4 
Live alone    
 No 60 48.4 
 Yes 64 51.6 
Income (n = 101)    
 < $25,000 47 46.5 
 $25,000 - $50,000 40 39.6 
 $50,000 - $100,000 12 11.9 
 > $100,000 2 2.0 
Take NSAIDS    
 No 29 23.4 
 Yes 95 76.6 
Note. aAge: M = 76.10, SD = 7.52  
N = 124 
 
Table 4 displays the frequency counts for the type of OTC NSAIDs categories 
used sorted by the highest frequency. The results showed that almost 77% of the sample 
reported taking NSAIDs. The most commonly used NSAIDs were aspirin (n = 46, 
37.1%) and acetaminophen (35.5%).  
Table 4 
 
OTC NSAIDs Categories Used by Highest Frequency  
 
NSAIDs category Frequency (N = 124) % 
Aspirin 46 37.1 
Acetaminophen 44 35.5 
Ibuprofen 32 25.8 
Naproxen 25 20.2 
Other NSAIDs  2 1.6 
Note. Multiple options were available on the survey. Overall, 95 respondents (76.6%) reported taking 
NSAIDs. 
 
Table 5 displays the frequency of NSAIDS use. The number of NSAIDs brands 
used ranged from 0 (n = 28, 22.6%) to four or more (n = 10, 8.1%; Mdn = 1). The number 
of NSAID brands included the generic name as well as the brand name for the same 
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active ingredient. It did not account for different labeling of the different products, as was 
reflected in the questionnaire. The number of NSAIDs days per month ranged from 0  
(n = 35, 28.2%) to 22 to 30 (n = 34, 27.4%; Mdn = 4). The number of NSAIDs treatments 
per day ranged from 0 (n = 37, 29.8%) to three or more (n = 11, 8.9%; Mdn = 1). For the 
88 respondents who answered the question pertaining to NSAIDs history, 73.9% (n = 65) 
reported using the drugs for longer than 6 months.  
Table 5 
Frequency Count of NSAIDs Consumption  
Variable Category Frequency (N = 124) % 
No. of NSAIDs brandsa    
 0 28 22.6 
 1 50 40.2 
 2 26 21.0 
 3 10 8.1 
 4 or more 10 8.1 
NSAIDs days/monthb    
 0 35 28.2 
 1-7 46 37.2 
 8-21 9 7.2 
 22-30 34 27.4 
NSAIDs treatments/dayc    
 0 37 29.8 
 1 50 40.3 
 2 26 21.0 
 3 or more 11 8.9 
NSAIDs history (n = 88)    
 1 week 4 4.5 
 2-3 weeks 3 3.4 
 1 month 4 4.5 
 2-3 months 7 8.0 
 4-6 months 5 5.7 
 > 6 months 65 73.9 
NSAIDs categories usedd 0 30 24.2 
 1 56 45.2 
 2 24 19.4 
 3 or 4 14 11.3 
Note. aBrands: Mdn = 1 
bDays: Mdn = 4 
cTreatments/day: Mdn = 1  
dCategories: M = 1.20, SD = 0.99 
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Table 6 displays the frequency counts for the awareness of adverse events sorted 
by the highest frequency. The most frequently endorsed awareness items were possible 
toxic interactions (n = 101, 81.5%) and gastrointestinal irritation (n = 99, 79.8%). The 
least endorsed awareness items were having personally experienced side effects (n = 21, 
16.9%) and awareness of the potential for an asthma attack (25.0%). An individual might 
have been aware of an adverse event because of personal experience or learning through 
others. 
Table 6 
Frequency Count of Awareness of Adverse Events Associated With NSAIDs Use  
Awareness item  n % 
Possible toxic interactions 101 81.5 
Gastrointestinal irritation 99 79.8 
Discuss with doctor 93 75.0 
Kidney toxicity 81 65.3 
Liver damage 79 63.7 
Asthma attack 31 25.0 
Experienced side effects 21 16.9 
Note. N = 124 
 
Table 7 displays the descriptive statistics from the Perceived Efficacy in Patient-
Physician Interaction Questionnaire (Maly et al., 1998) items sorted by the highest mean. 
These ratings were made based upon an 11-point Likert scale ranging from 0 (not 
confident at all) to 10 (extremely confident). The highest rated items (most confidence) 
were for Item 27, “Get a doctor to take your chief health concern seriously” (M = 8.27), 
and Item 31, “Ask your doctor for more information if you do not understand what he/she 
said” (M = 8.23). The lowest rated items (least confidence) were for Item 23, “Know 
what questions to ask your doctor” (M = 7.44), and Item 24, “Get a doctor to answer all 
of your questions” (M = 7.67).  
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Table 7 
Descriptive Statistics for Level of Communication Items Sorted by Highest Mean  
Communication item M SD 
27. Get a doctor to take your chief health concern seriously 8.27 2.63 
31. Ask your doctor for more information if you do not understand what he/she said  8.23     2.61 
30. Explain your chief health concern to a doctor 8.23 2.49 
25. Ask doctor questions about your chief health concern 8.21 2.62 
28. Understand what a doctor tells you 8.05 2.56 
29. Get a doctor to do something about your chief health concern 7.97 2.82 
22. Get a doctor to pay attention to what you have to say 7.88 2.89 
26. Make the most of your visit with your doctor 7.86 2.87 
24. Get a doctor to answer all of your questions 7.67 3.00 
23. Know what questions to ask your doctor 7.44 2.80 
Note. N = 124 
 
Table 8 displays the psychometric characteristics for the three summated scale 
scores. Cronbach’s alpha reliability coefficients were as follows: communication  
(α = .97); awareness (α = .67); and consumption (α = .76). All three scales had adequate 
levels of internal reliability. 
Table 8 
Psychometric Characteristics for the Summated Scale Scores   
Scale score No. of items M SD Low High α 
Communication 10 7.98 2.44 0.00 10.00 .97 
Awareness 7 4.07 1.75 0.00 7.00 .67 
Consumption 4 0.00 0.76 -1.23 2.15 .76 
Note. N = 124 
 
Answering the Research Questions 
Awareness of Risk and Sociodemographic Characteristics 
RQ1: To what extent does the awareness of the risk of adverse events associated 
with OTC NSAIDs use vary by sociodemographic characteristics among the elderly 
(SES, race/ethnicity, gender, and education)?  
71 
 
H01: There is no significant difference between awareness of the risk of adverse 
events associated with OTC NSAIDs use and sociodemographic characteristics among 
the elderly population.  
This question was examined, and the responses were assessed using the Pearson 
product-moment correlations and stepwise multiple linear regression. The results of these 
analyses indicated that none of the seven sociodemographic variables was related to the 
respondents’ awareness scores. As a subsequent analytical method, I used a stepwise 
multiple regression model to predict the respondents’ awareness scores based upon the 
seven sociodemographic variables. Given that none of the seven sociodemographic 
variables was significantly related to the respondents’ awareness scores, the stepwise 
multiple regression model contained no independent variables (i.e., no table shown). This 
combination of findings supported the retention of Null Hypothesis 1 (see Table 9). 
Table 9 
Pearson Correlations for the Awareness Scale With the Sociodemographic Variables  
Sociodemographic variables Awareness 
Age -.12 
Gendera -.07 
Marriedb .05 
Education .03 
Has a primary care doctorb .01 
Lives aloneb .01 
Income (n = 101) .18 
Note. aGender: 1 = Male 2 = Female  
bCoding: 0 = No 1 = Yes (N = 124) 
*p < .05  
p < .01  
p < .005  
p < .001 
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 Table 10 displays the results of the standard multiple regression model predicting 
awareness based upon the eight sociodemographic variables. The overall model was not 
significant (p = .52) and accounted for 6.3% of the variance in the respondents’ 
awareness scores. Inspection of the beta weights found none to be significantly related to 
the awareness scores.  
Table 10 
Standard Multiple Linear Regression Model Predicting Awareness Level Based Upon 
Sociodemographic Variables  
 
 
Variable B SE β p 
Intercept 5.35 2.69  .05 
Age -0.04 0.02 -.16 .14 
Gendera -0.23 0.42 -.06 .58 
Marriedb -0.22 0.61 -.06 .72 
Education -0.02 0.17 -.01 .92 
Has a primary care doctorb 1.25 1.83 .07 .50 
Lives aloneb 0.20 0.53 .06 .70 
Income 0.41 0.28 .18 .15 
Note. Full model: F(8, 115) = 0.89, p = .52, R2 = .063 
aGender: 1 = Male 2 = Female  
bCoding: 0 = No  1 = Yes   
N = 124 
Risk and Consumption 
RQ2: To what extent does awareness of the risk of adverse events associated with 
OTC NSAIDs consumption vary by rates of OTC NSAIDs consumption among the 
elderly population?  
H02: There is no significant difference between awareness of the risk of adverse 
events associated with OTC NSAIDs consumption among the elderly population.  
This question was answered using Pearson product-moment correlations and 
stepwise multiple linear regression. Table 11 displays the Pearson correlations between 
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the NSAIDs category variables and the awareness scores. None of the six correlations 
was significant at the p < .05 level. As a subsequent analytical method, I used a stepwise 
multiple regression model to predict the respondents’ awareness scores based upon the 17 
consumption variables. Given that none of the 17 consumption variables was 
significantly related to the respondents’ awareness scores, the stepwise multiple 
regression model contained no independent variables (no table shown). This combination 
of findings supported the retention of Null Hypothesis 2. 
Table 11 
Pearson Correlations Between NSAID Category Variables and Awareness  
NSAIDs category variables  Awareness 
Aspirin .12 
Acetaminophen .16 
Naproxen .01 
Ibuprofen -.09 
Other NSAIDsa -.12 
Total categories of NSAIDs used .09 
Note. p < .05  
N = 124 
Awareness and Communication 
RQ3: To what extent are levels of awareness of adverse events associated with 
OTC NSAIDs consumption and levels of communication with their physicians among the 
elderly population?  
H03: There is no significant difference between awareness of adverse events 
associated with OTC NSAIDs consumption and the level of communication with 
physicians among the elderly population. 
This question was answered using Pearson product-moment correlations and 
stepwise multiple linear regression. Inspection of Table 12 found all 11 communication 
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variables associated with the respondents’ awareness scores. The two strongest 
correlations were for Item 22, “Get a doctor to pay attention to what you have to say”  
(r = .31, p < .001), and Item 23, “Know what questions to ask your doctor” (r = .30,  
p < .001). 
Table 12 
 
Pearson Correlations for Awareness Scale With Communication Variables  
 
Communication variable Awareness   
Communication total score .29 **** 
22. Get a doctor to pay attention to what you have to say .31 **** 
23. Know what questions to ask your doctor .30 **** 
24. Get a doctor to answer all of your questions .28 *** 
25. Ask doctor questions about your chief health concern .22 * 
26. Make the most of your visit with your doctor .26 *** 
27. Get a doctor to take your chief health concern seriously .22 ** 
28. Understand what a doctor tells you .27 *** 
29. Get a doctor to do something about your chief health concern .25 *** 
30. Explain your chief health concern to a doctor .23 ** 
31. Ask your doctor for more information if you do not understand what he/she 
said .28 *** 
Note. *p < .05  
**p < .01  
***p < .005  
****p < .001 
 
As a subsequent step, I used a stepwise multiple regression model to predict the 
respondents’ awareness scores based on the 11 communication variables (total 
communication score + 10 individual communication items). The final 1-variable model 
was significant (p = .001) and accounted for 9.5% of the variance in the respondents’ 
awareness levels. Table 13 shows that awareness level was positively correlated with 
Item 22, “Get a doctor to pay attention to what you have to say” (β = .31, p = .001). This 
combination of findings (see Tables 11 & 12) supported the rejection of Null Hypothesis 
3.  
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Table 13 
 
Stepwise Multiple Linear Regression Model Predicting Awareness Level Based Upon 
Selected Variables  
 
Variable B SE β p 
Intercept 2.60 0.44  .001 
22. Get a doctor to pay attention to what you have to say 0.19 0.05 .31 .001 
Note. Full model: F (1, 122) = 12.87, p = .001 R2 = .095 
Candidate variables = 10 
N = 124 
 
Summary 
  I conducted this study to determine whether elderly patients are aware of the risks 
associated with the consumption of OTC NSAIDs. The results, which were based upon a 
cross-sectional survey of 124 participants, showed that the participants’ awareness of 
adverse events associated with NSAIDs use was not associated with the 
sociodemographic variables, so Null Hypothesis 1 was supported. The results also 
showed that the participants’ awareness of the risks was not related to their rates of 
consumption, so Null Hypothesis 2 was also retained. In addition, the results showed that 
awareness was related to patient-physician communication, so Alternative Hypothesis 3 
was supported. In the final chapter, these findings are compared to results in the 
literature, conclusions and implications are drawn, and recommendations are offered. 
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Chapter 5: Discussions 
Introduction 
The purpose of this study was to examine the association between the use of OTC 
NSAIDS to self-medicate by individuals in the elderly population and their awareness of 
the risks associated with NSAIDS use. The goals of the study were to assess  
(a) whether there is an association between awareness of risks of adverse events 
associated with OTC NSAIDS use and OTC NSAIDS consumption, (b) whether this 
awareness of the risk of the adverse effects of OTC NSAIDS varies by sociodemographic 
characteristics, and (c) whether awareness of the risk of adverse events is associated with 
the level and type of communication between patients and physicians. I collected the data 
from a sample of 124 elderly individuals in a metropolitan area in the Midwestern United 
States from senior citizen community centers. Included in Chapter 5 are my interpretation 
of the results based upon the current literature and theoretical framework and an 
explanation regarding the ways in which these findings can provide valuable information 
on OTC NSAIDs as well as recommendations for future research.  
I used a quantitative, cross-sectional design to conduct a study regarding the 
participants’ medication use, attitudes and beliefs about the use of OTC NSAIDs, levels 
and types of communication with their physicians, and sociodemographic characteristics. 
The information obtained from the paper-and-pencil survey helped me to assess the 
health needs of the elderly population. The findings and conclusions are discussed to 
compare the results of the research to previous findings described in the literature, draw 
77 
 
conclusions and implications, and offer recommendations associated with the self-
medication of OTC NSAIDs.  
  Afolabi (2012) estimated that approximately 50% to 75% of health care expenses 
are associated with self-medication. However, self-medication is not without risks, 
despite the advantages associated with patient empowerment (Hughes et al., 2001). When 
individuals choose to self-medicate, they are engaging in help-seeking behavior 
(Klemenc-Ketis & Kersnik, 2011). Individuals who choose to self-medicate must be sure 
that the medications are appropriate for their chronic or recurrent conditions and have 
proven records of safety, quality, and efficacy (WHO, 1998). Such knowledge will not 
only help to bridge the gap between physicians and policymakers but also improve the 
targeting of specific patient populations to the extensive consumption of OTC NSAIDs 
by the elderly population. This knowledge also will help to increase the awareness of this 
population about the side effects of these medications.  
The results of this study, which were based upon a cross-sectional survey of 124 
participants, showed that the participants’ awareness of adverse events associated with 
NSAIDs use was not associated with the sociodemographic variables, so Null Hypothesis 
1 was supported. The results also showed that the participants’ awareness of the risks was 
not related to their rates of consumption, so Null Hypothesis 2 also was retained. In 
addition, the results showed that awareness was related to patient-physician 
communication, so Alternative Hypothesis 3 was supported. In the final chapter, these 
findings are compared to results in the literature, conclusions and implications are drawn, 
and recommendations are offered. 
78 
 
Interpretation of the Findings 
 In some countries, the number of OTC medications is monitored through 
government-regulated systems (Balbuena et al., 2009). However, in the United States, 
OTC purchases are not monitored, thus making it difficult to identify the characteristics 
of the individuals who are the most likely to self-medicate and gain a better 
understanding of the different patterns of consumption within various geographic 
locations within the elderly population ages 65 years and older. 
The results of this study were based upon collecting data from individuals from 
two senior citizen community centers in a metropolitan area in the Midwestern United 
States. The sociodemographics of the participants reflected the geographic area where the 
study was conducted and corresponded to similar statistics found across the Midwestern 
state by the U.S. Census Bureau (2012). The participants were 98.8% Caucasian/White), 
60.5% had a level of education reflecting some college education or more, and 86.1% had 
an annual income of less than $50,000. Because of the sociodemographic characteristics 
of that particular Midwestern state, it would be beneficial for future research to be 
conducted in other geographic locations across the United States and include more 
diverse samples relevant to race/ethnicity. The participants in the current study did reflect 
the national population of 77.9% European American (U.S. Census Bureau, 2012). 
Despite the lack of diversity in the sample, the results will expand current understanding 
of the level of awareness among elderly individuals about their consumption of OTC 
NSAIDS and provide a foundation to improve levels of education, enhance the 
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dissemination of information, and identify gaps that future research initiatives might be 
able to address.  
There has been insufficient data in the United States evaluating the relationship of 
levels of education, gender, ethnicity, marital status, living arrangements, and SES to 
OTC medication consumption, including the consumption of NSAIDs. An international 
study by Balbuena et al. (2009) highlighted the relationship between the consumption of 
OTC medications and sociodemographic characteristics. More than 50% of the 
participants consumed OTC medications within a 30-day period. In addition, self-
medication was significantly greater among the participants who lived independently than 
among married couples (p = .0274) as well as those who were illiterate or had low levels 
of education than among participants who had graduated from high school (p = .0036).  
You et al. (2011) conducted a cross-sectional phone survey of approximately 
1,100 noninstitutionalized individuals in Hong Kong to evaluate their knowledge about 
the use of OTC medications and the associated risk factors. The results showed that 
participants who had no formal education or just a primary education (OR = 3.19;  
p < .001); had a secondary school education (OR = 1.50; p = .035); and were > 60 years 
of age (OR = 1.82; p = .042) were more likely to be less knowledgeable of self-
medication and the risk factors associated with using OTC medications (You et al., 
2011). In addition, the literature has reported that the consumption of NSAIDs is more 
frequent among females and increases with age (Lanas & Ferrandez, 2007).  
The results of this study showed that of 75.8% the female and 76.6% of the male 
participants consumed NSAIDs. These results were similar to previous studies. For 
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example, Solomon (2003) conducted a study in Nigeria and found a high prevalence of 
self-medication among females (61.9%); Angeles (1992) reported similar results in 
Mexico (46%). The results of this study showed that 61% of the participants had attended 
at least some college courses and that 25.0% of the participants had earned a college 
degree. The level of education documented by Baig et al. (2012) indicated that 28.4% of 
the graduates in their study self-medicated.  
Despite the fact that the majority of research compiled outside the United States 
has identified differences between sociodemographic characteristics and the percentage 
of people who engage in self-medication, the results of the current study indicated that 
none of the seven sociodemographic variables was associated with the participants’ 
awareness of the risk of adverse events associated with OTC NSAIDs use. The results of 
this study identified the following frequency counts for OTC NSAIDs use: aspirin 
(37.1%), Tylenol (29.8%), and ibuprofen (17.7%). The number of NSAIDs brands used 
ranged from 0 (22.6%) to four or more (8.1%), and the number of NSAIDs days per 
month ranged from 0 (28.2%) to 22 to 30 (27.4%). In addition, frequency counts for the 
OTC NSAID categories were evaluated. The most commonly used NSAIDs categories 
were aspirin (37.1%) and acetaminophen (35.5%). The frequency of medications 
consumed might be dependent upon the dosage regimens of the OTC NSAIDs I question; 
however, the variability also might be the result of individuals deciding to self-medicate.  
In a self-medication survey by Neafsey and Shellman (2001), the participants 
reported NSAIDs consumption, 46.9% reported taking NSAIDs for pain for 3 or more 
days at a time, and 36.7% reported taking NSAIDs daily for pain. The Sloan Survey, 
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which was conducted in the United States, found that more than twice as many people 
used acetaminophen (23%), ibuprofen (17%), or aspirin (17%) than any other OTC 
medications (as cited in McDonald et al., 2007). Similar results were reported in a survey 
in Finland, where 27% of the participants reported consuming OTC analgesics a few 
times each week (as cited in McDonald et al., 2007). However, based upon the literature, 
at least 25% of patients consuming NSAIDs have experienced adverse events, and many 
of these patients have required medical attention or possible hospitalization (Lanas & 
Ferrandez, 2007).  
For the 88 respondents who answered the question about NSAIDs history, 73.9% 
reported taking the drugs for more than 6 months. According to the National Consumers 
League (2009), more than 175 million people in the United States are taking OTC 
medications for pain. Wilcox et al. (2005) contended that 36 million American are taking 
OTC pain medications daily and approximately 23 million are taking NSAIDs. Based 
upon the consensus reached by the American College of Cardiology, the American 
College of Gastroenterology and the American Heart Association, 70% of individuals in 
the elderly population consume NSAIDs once a week and 34% use them daily (as cited in 
American College of Cardiology Task Force, 2008). NSAIDs use is one of the most 
common causes of reported serious adverse reactions to drugs involving the 
gastrointestinal tract, cardiovascular system, liver, and kidneys (Barkin et al., 2010; 
Pineles & Parente, 2012). For example, acetaminophen, a common analgesic in the 
United States, has been reported as causing 78,414 emergency room visits and 26,000 
hospital admissions annually (Budnitz et al., 2011; Lee, 2007; Nourjah et al., 2006).  
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Conaghan (2012) reported that NSAIDs consumption can be associated with an 
increased risk of cardiovascular events such as myocardial infarction, heart failure, and 
hypertension that are dependent upon the duration of exposure. Conaghan also found that 
the consumption of NSAIDs reported by the participants in the study resulted in 
gastrointestinal complications in approximately 30% of patients. In the current study, the 
participants were very aware of adverse effects associated with the consumption of 
NSAIDs, except for asthma. The most frequently known adverse effects were possible 
toxic interactions (81.5%) and gastrointestinal irritation (79.8%). A standard multiple 
regression model predicting awareness based upon the eight sociodemographic variables 
did not show any statistically significant difference and accounted for 6.3% of the 
variance in the respondents’ awareness scores. 
Researchers also have documented that NSAIDs can cause gastrointestinal 
complications (Tamer et al., 2000). The least endorsed awareness items in this study were 
personal experience of having side effects (16.9%) and awareness of the potential for 
asthma attack (25%). The results of the study showed no significant difference between 
awareness among the elderly population of the risk of adverse events and OTC NSAIDs 
consumption. No current literature in the United States has evaluated the rates of 
consumption and the risk associated with adverse events. 
The quality of the physician-patient relationship and the level of communication 
between physicians and patients also have been shown to be related to patient outcomes 
(Funnell, 2011; Ratanawongsa et al, 2008; Verlinde et al., 2012). A higher quality of 
communication and trust influences patient satisfaction, compliance, and recall of 
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medical information. As a result, the health status among the elderly population can 
improve as communication with their physicians improves and becomes more honest and 
open. As demonstrated in the current study, 75% of the participants indicated that they 
had discussions with their physicians about the need to be award of the side effects of 
taking OTC NSAIDs.  
The results of the current study associated with Research Question 3 identified a 
significant difference between the participants’ awareness of the adverse events 
associated with OTC NSAIDs consumption and their levels of communication with their 
physicians. The results of the survey indicated that the participants had excellent levels of 
communication with their physicians, perhaps because they and their physicians 
recognized the value of consistently honest, open, informative, and bidirectional 
communication.  
Support of the Conceptual Framework 
 The findings support the conceptual framework of the HBM, which is divided 
into three categories: (a) individual perceptions (i.e., perceived susceptibility to adverse 
event and the perceived seriousness of the adverse event); (b) modifying factors (i.e., 
demographic, sociopsychological, and structural variables); and (c) the likelihood of 
action (i.e., perceived benefits of preventative action). The HBM specifies the 
interactions of values and beliefs about health and their influences on choices.  
 In the current study, the participants were aware of the adverse events associated 
with the consumption of OTC NSAIDs and understood their susceptibility to such events 
related to consuming OTC NSAIDs. This high level of awareness was most likely the 
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result of the strong patient-physician levels of communication within this geographic 
location. The participants also had high levels of trust in their physicians, and they felt 
comfortable consuming OTC NSAIDs because their physicians were aware of their levels 
of consumption and understood that their medical status supported their consumption of 
OTC NSAIDs. Within the context of the medical needs of the elderly population, OTC 
NSAIDs consumption might not need to be changed.  
The HBM provides the framework for people to change their behavior that can 
include such elements as mass media campaigns to raise awareness of adverse events 
associated with the consumption of OTC NSAIDS and improved communication 
between elderly patients and physicians. This model might influence individuals’ beliefs 
about the potential for adverse reactions related to OTC NSAIDs consumption, their need 
to determine whether the threat is real enough to adopt behavior modification, and their 
need to improve levels of communication with their physicians.  
Recommendations for Future Research 
Future Research Questions 
 The results identified the importance of obtaining information to compare the 
findings to other geographic areas within the United States. The results also supported the 
need to educate the elderly population about the importance of strong patient-physician 
communication to understand the adverse side effects associated with the consumption of 
OTC NSAIDs. It also is important to focus on specific patient cohorts within the elderly 
population, such as individuals who have chronic renal insufficiency and other medical 
complications, to understand their level of awareness of the adverse effects associated 
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with the consumption of OTC NSAIDs. These different types of patient populations have 
comorbidities, so the impact of self-medicating with OTC NSAIDs will vary among these 
patients. Future researchers also might want to study possible measures that the health 
care system could take to improve the safety of OTC NSAIDs use.  
Patients tend to self-manage their pain to improve their daily activities by 
consuming OTC NSAIDs, so future researchers might consider investigating and 
evaluating the sociodemographic factors (race/ethnicity, marital status, education, and 
income) associated with the consumption of multiple OTC NSAIDs. For example, 
conducting research over a wider geographic expanse might facilitate a more complete 
examination of sociodemographic differences. Determining the level of consumption of 
multiple OTC NSAIDs in the United States is difficult because no systems are in place to 
record such numbers, especially those associated with pharmacy claims or medical 
records. There is a lack of a well-accepted standardized measure to capture OTC 
consumption. It might be advantageous to research opportunities to develop and then 
implement technological systems to track consumption, a process that could help to 
increase the awareness of adverse events and decrease the number of preventable adverse 
events.  
Best Practices to Improve Outcomes 
Self-care that involves OTC medications, including NSAIDs, is very common 
among the elderly population. As the number of OTC medications continues to increase, 
so, too, does the risk of drug interactions and preventable adverse events. It is important 
to understand patterns of consumption to ensure individuals’ health and reduce the risk of 
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preventable adverse events. It is important for physicians to communicate openly with 
their patients and routinely ask them about their OTC consumption of medications.  
Patients need to be honest and tell their physicians exactly what OTC medications 
they are consuming. Enhanced lines of communication are beneficial, particularly when a 
patient has received a new diagnosis or a prescription for a medication that would alter a 
medical profile. Joint efforts with organizations such as the Centers for Education and 
Research on Therapeutics to conduct research and educate medical students, residents, 
research fellows, other allied health professionals, and the elderly population will help to 
advance the best use of OTC NSAIDS. Customized education campaigns could be an 
effective tool to promote their understanding. Collaborative efforts with representation 
from the elderly population, peer networking, and computer technology/social media 
could be used to reach the intended audience.  
Additional education and research can provide guidance and direction to 
physicians, patients, and policymakers so that they can make informed decisions about 
their treatment options (self-medication vs. physician direction). Such research could 
include a value-tree method that could help to define the risks and benefits of consuming 
OTC NSAIDs. This type of research would facilitate an exploration of different 
possibilities and consequences in an effort to quantify decisions and help to build 
relationships with stakeholders to implement activities that support the elderly 
population. The results of this research can be used to identify gaps in awareness. 
Understanding the risks and benefits of medical therapies is critical to improving the 
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safety and effectiveness of their use and consumption and ensuring that patients and 
physicians have the knowledge to use medical therapies appropriately.  
Social Change 
 The findings of this study are beneficial in showing stakeholders and 
policymakers the value of initiating educational campaigns that will improve individual 
choices in regard to the consumption of OTC NSAIDS and help to reduce preventable 
adverse events. Community programs based upon collaboration between health care 
professionals and organizations might help to reduce the number of adverse drug 
reactions. This quality initiative, along with the sharing of the results of this study with 
stakeholders at the local and national levels, will help to drive new initiatives and 
research in other areas area of the United States. It will support implementation of safer 
practices and strategies by increasing awareness associated with the consumption of OTC 
NSAIDs throughout the United States. The findings have implications for social change 
in that they will give different key stakeholders (i.e., health care professionals, health care 
organizations, and government agencies) more insight into the issue of preventable 
adverse events that might lead to the creation of more safety programs and informatics 
structural systems to monitor the consumption of OTC NSAIDs and improve lines of 
communication to protect the elderly population.  
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Appendix A: OTC NSAIDs Survey 
This survey is designed to better understand the use of OTC NSAIDS and patient-
physician communication. Please select one response for each of the questions. Your 
responses will help us understand the over-the-counter non-steroidal anti-inflammatory 
(NSAID) medication use in different population groups.  
(1)Age: ___________ (Years) 
(2) Sex 
(a) Male  
(b) Female 
(3) Ethnicity  
(a) White  
(b) Black  
(c) Hispanic  
(d) Other 
(4) Marital Status  
(a) Married  
(b) Widowed 
(c) Single  
(d) Divorce/Separated 
(5) What is the highest level of education you have attained? 
(a)  Less than high school 
(b)  High School graduate 
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(c)  Some college 
(d)  College graduate 
(e)  Graduate level degree 
(6) Do you have a primary care physician?  
(a) Yes  
(b) No 
(7) Do you live alone? 
(a) Yes  
(b) No 
(8) What is your annual income? 
(a) Income < $25,000 
(b) Income > $25,000 and < $50,000 
(c) Income > $50,000 and < $ 100,000 
 Income > $100,000  
9) Do you take over-the-counter NSAIDS? 
(a) Yes 
(b) No  
 If you answered yes to Question 9, which over-the-counter NSAIDS do you use? 
(Please circle all that apply.) 
 Ibuprofen (Advil, Motrin, Nuprin, Medipren) Naproxen (Aleve) Aspirin  
 Acetaminophen (Tylenol) Other  
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10) What is the total numbers of over-the-counter NSAIDS you are currently taking? 
0 1 2 3 4 5 6 7 8 9 10+ 
11) In the PAST MONTH, circle about how many DAYS you take OTC NSAIDS. 
0 1-7 8-14 15-21 22 -30 
12) In the PAST MONTH, circle about how many TIMES PER DAY you took OTC 
NSAID medication. 
0 1 2 3 4 5 or more 
13)  Please circle how long how long you have been taking OTC NSAIDS. 
1 WEEK 2-3 WEEKS 1 MONTH 2-3 MONTHS 4-6 MONTHS LONGER 
THAN 6 MONTHS 
14) Do you discuss with your physician your use of over-the-counter NSAIDS?  
(a) Yes  
(b)  No 
15) Have you ever experienced any side effects as a result of taking over-the-counter 
NSAID medications?  
(a) Yes  
(b) No  
If you answered “yes” to Question 15 how would you describe the side affects you  
experienced? Please choose one. 
(a) Mild side effects. 
(b) Moderate side effects 
(c) Strong/painful side effects 
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(d) N/A 
16) Were you aware that over-the-counter NSAIDS can possibly cause toxic interactions 
with other medications that you are taking?  
(a) Yes  
(b) No 
17) Were you aware that therapeutic doses of Aspirin, Ibuprofen, and Naproxen can 
cause or worsen gastrointestinal irritation and bleeding especially in individuals with a 
history of gastrointestinal disease?  
 (a)Yes 
 (b) No 
18) Were you aware that if you have asthma, Aspirin may increase the likelihood of 
asthma attack?  
(a)Yes 
(b) No 
19) Were you aware that Aspirin, Ibuprofen, and Naproxen can cause kidney toxicity 
especially in individuals with a history of kidney disease? 
 (a)Yes 
 (b) No 
20) Were you aware that in chronic doses, Acetaminophen can cause liver damage, 
especially in people with regular alcohol intake?  
(a)Yes  
(b) No 
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21) If you had been aware of the adverse side effects of over-the-counter NSAID 
medications when you started taking them, would it have made you think twice about 
how much you use them? Please select one answer. 
(a) Yes, now that I am aware of over-the-counter NSAIDs’ side effects, I 
wouldn’t have used them at all. 
(b) Yes, I would think twice about using them and take them with more caution. 
(c)  No, whether or not over-the-counter NSAIDS are harmful, I have no other 
option for pain relief. 
The following questions will help understand the level of communication between 
yourself and your primary care physician. For each statement, please indicate your level 
of confidence. 
How confident are you in your ability to: 
22. Get a doctor to pay attention to what you have to say:  
[0 = not confident at all, 10 = extremely confident] 
0 1 2 3 4 5 6 7 8 9 10 
23. Know what questions to ask your doctor: 
[0 = not confident at all, 10 = extremely confident] 
0 1 2 3 4 5 6 7 8 9 10 
24. Get a doctor to answer all of your questions: 
[0 = not confident at all, 10 = extremely confident] 
0 1 2 3 4 5 6 7 8 9 10 
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25. Ask doctor questions about your chief health concern: 
[0 = not confident at all, 10 = extremely confident] 
0 1 2 3 4 5 6 7 8 9 10 
26. Make the most of your visit with your doctor: 
[0 = not confident at all, 10 = extremely confident] 
0 1 2 3 4 5 6 7 8 9 10 
27. Get a doctor to take your chief health concern seriously: 
[0 = not confident at all, 10 = extremely confident] 
0 1 2 3 4 5 6 7 8 9 10 
28. Understand what a doctor tells you: 
[0 = not confident at all, 10 = extremely confident] 
0 1 2 3 4 5 6 7 8 9 10 
 29. Get a doctor to do something about your chief health concern: 
[0 = not confident at all, 10 = extremely confident] 
0 1 2 3 4 5 6 7 8 9 10 
30. Explain your chief health concern to a doctor: 
[0 = not confident at all, 10 = extremely confident] 
0 1 2 3 4 5 6 7 8 9 10 
31. Ask your doctor for more information if you do not understand what he/she said: 
[0 = not confident at all, 10 = extremely confident] 
0 1 2 3 4 5 6 7 8 9 10 
THANK YOU FOR YOUR PARTICIPATION.
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Appendix B: Permission to Use Instruments 
 
--- On Fri, 3/29/13, Amy Ernst <AErnst@salud.unm.edu> wrote: 
 
From: Amy Ernst <AErnst@salud.unm.edu> 
Subject: Re: Michelle Popa: PhD Student Walden University: Publication Request 
To: micki_vasile@yahoo.com 
Date: Friday, March 29, 2013, 3:47 AM 
It's fine with me. To publish the full survey in a journal would require permission from 
the journal though.  
Best of luck 
Amy 
>>> MICHELLE POPA 03/28/13 6:12 PM >>> 
Amy, 
  
Thank you so much for your email. That is perfect. I would like to confirm that you will 
give me permission to use your instrument in my research. I look forward to hear from 
you. Thank you again for your time and support. 
  
Regards, 
Michelle 
 
April 26, 2013 
 
Michelle, 
 
PEPPI is in the public domain and my official permission is not needed to use it--you just need to 
reference the original PEPPI validation study if you publish using it.  
 
Best of luck with your research, 
Rose Maly, MD, MSPH 
_________________________________ 
  
Rose C. Maly, MD, MSPH 
Associate Professor of Family Medicine 
George F. Kneller Chair in Family Medicine 
David Geffen School of Medicine at UCLA 
10880 Wilshire Blvd., Suite 1800 
Los Angeles, CA 90024 
Phone: 310-794-6091 
Fax: 310-794-6097 
E-Mail: rmaly@mednet.ucla.edu 
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